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Abstract 
 
The two-component based chemotaxis signal transduction system allows flagellated 
bacteria to sense their surrounding chemical environment and move towards more 
favorable conditions. The attractant signals can be sensed by transmembrane 
chemoreceptors, and then transmitted to the histidine kinase CheA. Once activated, CheA 
interacts with the response regulator CheY through phosphorelay, which causes a change 
in the rotation of the flagella. The direction of flagella rotation determines whether a cell 
swims straight or just tumbles. Cells also need adaptation to respond to a change in 
chemical concentrations, and return to their prestimulated level. Adaptation in the B. 
subtilis chemotaxis system is achieved by three coordinated systems: the methylation 
system, the CheC/CheD/CheY-p system and the CheV system. CheD, the previously 
identified receptor deamidase, was shown to be critical to the ability of B. subtilis to 
perform chemotaxis and is the main focus of this study. 
 This study started from characterization of the enzymatic mechanism of CheD. 
Results showed that CheD deamidase uses a cysteine hydrolase mechanism. The catalytic 
triad consisting of Cys33-His50-Thr27, and Ser27 is essential for receptor recognition 
and binding.  
In addition, in this study CheC was found to inhibit CheD’s deamidase activity. 
Through mutant screening, Phe102 on CheD was found to be the essential site to interact 
with CheC. Furthermore, the CheD/CheC interaction is necessary for the robust 
chemotaxis in vivo as demonstrated by the cheD (F102E) mutant, which lacks the ability 
to swim on swarm plates. 
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Despite its deamidase activity, we hypothesized that CheD’s main role is its 
involvement in the CheD-CheC-CheY-p negative feedback pathway during adaptation. In 
particular, CheD is likely to help stabilize the transient kinase-activating state through 
binding to receptors. When CheY-p level is increased, CheC-CheY-p complex may 
attract CheD away from receptors. In this study, CheC-CheD binding kinetics with CheY 
or CheYp presence was successfully obtained by a series of SPR experiments. The 
increased affinity of CheD for CheC in presence of CheYp but not CheY makes likely the 
hypothesis that CheC-CheD-CheY interact as part of a negative feedback pathway during 
adaptation. 
Last, the interaction between CheD and chemoreceptor McpC was studied in order 
to better understand the role of CheD in adaptation. Results showed that Q304 and Q305 
on McpC are essential to recruit CheD. Additionally, the reduced levels of CheD in mcpC 
(Q304A) or (Q305A) mutants suggested that the dynamic interaction between CheD and 
receptors is vital to maintain the normal CheD level. 
These findings suggest more complicated roles of CheD than its previously 
identified function as a receptor deamidase, and will lead to a clearer picture of the 
coordination of the three adaptational systems in the B. subtilis chemotactic sensory 
transduction system. 
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Chapter 1 
Introduction 
 
Bacterial Movement and Chemotaxis 
Microorganisms living in nature do not always face harmonious living conditions. Often 
they have to face a variety of hostile and challenging environmental conditions, e.g. lack of 
food, competition for nutrients, chemical toxin attacks, constantly changing temperatures, 
osmotic stress, etc. To survive and thrive in harsh environments, microorganisms developed 
the ability to move during evolution. Bacterial motility was first discovered in 1676 by 
Antoni van Leeuwenhoek [27]. Motility lets a microorganism swim towards a nutrient 
source and away from hostile environments. This process is known as chemotaxis, which has 
been extensively studied since discovered by Julius Adler in 1965 [1, 2] (Figure 1.1). 
Bacterial movement is achieved by different mechanisms, including flagella [4, 15, 65], 
pili [102, 121], and gliding [69, 88]. The core chemotactic signal transduction systems are 
similar and relatively conserved among bacteria and archaea. They are all based on the 
two-component system, albeit flagella in the archaea shows no homology to flagella in 
bacteria [113].  
Even in bacteria, the flagella number and position vary among different species. The 
gram-positive bacterium Bacillus subtilis and the gram-negative bacterium Escherichia coli 
have 6-12 flagella, which can form a flagella bundle during swimming mode [3, 126]. 
Thermotoga maritima has a single polar flagellum [35], and the spirochetes have several 
flagella located at each of two ends of the cell [14]. Despite using different mechanisms for 
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flagella-mediated motility, all bacteria use a similar core two-component system for 
chemotaxis. 
 
The Two-Component Signal Transduction System 
Two-component signal transduction systems widely exist in bacteria and archaea and 
rarely in the eukaryotes. They are the predominant mechanism of signal transduction in 
bacteria and archaea [106]. The two-component systems enable bacteria to respond and 
adapt to a wide range of environmental signals, including nutrients, toxins, stressors, cellular 
redox state, changes in osmolarity, quorum signals, and antibiotics [59]. Different bacteria 
and archaea may have different numbers of two-component systems that need to be tightly 
regulated to avoid unnecessary cross-talk. Some bacteria can contain up to as many as 200 
two-component systems [59]. Synechocystsis sp. has as many as 80 two-component systems, 
while Mycoplasma genitalium does not contain any two-component systems [75, 73]. E. coli 
has 30 two-component systems and the B. subtilis has 70 two-component systems [28, 74].  
Two-component systems mainly consist of a sensor histidine kinase (HK) and its 
cognate response regulator (RR). Upon activation, the HK catalyses its own 
autophosphorylation on a conserved histidine residue followed by transfer of the phosphoryl 
group to a conserved aspartate on the response regulator, which can induce many 
downstream biological effects. Phosphorylation induces a conformational change in its 
output domain. Thus, the RR is activated (Figure 1.2). The output domains of RR are usually 
DNA-binding domains. But in chemotaxis, CheY (RR) is not a DNA-binding protein. 
Instead, upon phosphorylation it will bind the switch proteins in the flagella base body and 
alter the direction of flagellar rotation (Figure 1.2). The system can be re-set by 
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dephosphorylation of RR. Therefore, bacteria can constantly sense the external signals. The 
activated RR can act as quickly as several seconds (half-life of RR-p), so that cells can 
response to the environmental signals quickly and efficiently [106].  
Interestingly, there is some cross-talk between different two-component systems. For 
example, the NtrB-NtrC pathway is important in nitrogen assimilation, and studies on the 
NtrB-NtrC and CheA-CheY pathways found that both NtrB and CheA kinases can 
phosphorylate NtrC [80]. Furthermore, overexpression of the histidine kinase NtrB in a cheA 
− strain of E. coli showed smooth swimming behavior, indicating the cross-phosphorylation 
of CheY by NtrB. It has also been verified by in vitro NtrB-CheY phosphorelay assay [80]. 
In our case, it will be interesting to investigate potential cross-talks between CheA-CheY 
pathway and other two-component pathways. It will be more biologically meaningful as cells 
may be facing with different growth or environmental signals at a certain time point.  
 
The Chemotaxis Signal Transduction System 
Flagellated bacteria can move towards favorable environment by controlling the 
direction of flagella rotation. When rotating counterclockwise (CCW), due to the inherent 
structural chirality, the flagella form into a bundle at a pole of the B. subtilis cell. Then the 
cell swims smoothly. When rotating clockwise (CW), the flagella bundle falls apart, and the 
cell tumbles. In an isotropic environment, a bacterium will have a 55% of CCW rotation 
(smooth swimming) and 45% CW rotation (tumbling), resulting a random 3-D walk and little 
net migration [11, 64, 68, 112]. When an attractant signal is sensed, the flagella bundle will 
increase the frequency of CCW rotation resulting a net swimming towards higher 
concentrations of attractant (Figure 1.3). Once there is no change of chemical gradient 
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sensed, the bacterium will adapt to the environment and return to its pre-stimulus 55/45 bias 
[53, 90]. 
Over the past 40 years, E. coli has been extensively studied as the model organisms for 
bacterial chemotaxis. The chemotaxis signal transduction system is based on the modified 
two-component system. In this system, CheA acts as the histidine kinase and CheY is its 
cognate response regulator. These two proteins are the core proteins of the chemotaxis 
two-component system. However, there are some differences from traditional 
two-component systems. The HK CheA is not a transmembrane protein, but a cytosolic 
protein that lacks a sensing domain. Therefore, it does not directly interact with an 
extra-cellular ligand. In this case, chemoreceptors, methyl-accepting chemotaxis proteins 
(MCPs), bind the external ligand [55, 84, 93, 124]. The binding will induce conformational 
changes on MCPs, which activates CheA autophosphorylation via a highly conserved 
domain (HCD) with the aid of the coupling protein CheW [5]. Once CheA is phosphorylated, 
it will promote CheY phosphorylation at the conserved aspartate residue. The activated 
CheY (CheYp) will then interact with switch proteins at the flagella base motor, which 
induces the change of flagella rotation (Figure 1.4). The whole chemotaxis cycle includes 
two steps, excitation and adaptation, which will be discussed further later. 
Beside CheA-CheY core proteins, there are many more Che proteins involved for fully 
functioning chemotaxis. Individual proteins will be discussed next and summarized in Table 
1.1.  
 
A. The Core Proteins CheA and CheY   
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The histidine kinase CheA is a 74.5-kDa protein with five different domains (Figure 
1.5). It is a homodimer with different domains connected to one another via flexible linkers 
[16]: (a) The P1 (histidine phospho-transfer or HPT) domain is a four-helix bundle 
containing the conserved histidine residue that can be phosphorylated by the kinase domain 
[77]; (b) The P2 domain is responsible for CheY binding [70, 76, 82, 105]; (c) The P3 
domain is responsible for CheA dimerization [37, 100]; (d) The P4 domain is the catalytic 
domain, and, along with the P3 domain, forms the core common to all histidine kinases [16, 
17]; and (e) the P5 domain is responsible for interacting with both CheW and the tip of 
MCPs, and also shares considerable homology with CheW [16, 19, 20]. Due to its large size, 
the detailed mechanism of CheA autophosphorylation is still not very clear. The P4 domain 
has several conserved regions including the N-box, G1-box, F-box, G2-box, and GT block, 
which are essential for catalysis and are thought to be involved in positioning of ATP into 
the active site [40].  
Unlike CheA, the response regulator CheY is a small protein. It is a one-domain, 13 
kDa protein with a length of about 120 amino acids. CheY can catalyze both its 
autophosphorylation and autodephosphorylation. CheZ in E. coli, CheC and FliY in B. 
subtilis increase the rate of CheY-p dephosphorylation [39, 100]. Several conserved residues 
are important for CheY activity, including two adjacent N-terminal aspartate residues that 
bind Mg2+, the phosphorylatable aspartate located in the center of the protein, and a 
threonine and lysine located at the carboxy-terminus involved in catalysis of phosphorylation 
[62, 117, 127, 128]. Once phosphorylated, CheYp interacts with FliM in the flagella switch 
complex that promotes a change in flagellar rotation [96, 101, 115, 118]. In addition, CheYp 
has a very fast turnover rate compared to other RRs, and its half life varies from 10s to 30s in 
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different organisms. The fast CheYp turnover rate ensures cells to response quickly to the 
changing environment [94].  
 
B. The Chemoreceptors   
The chemoreceptors are responsible for ligand binding and transferring the signal to the 
downstream HK CheA via conformational changes mediated by scaffolding proteins CheW 
and CheV.  
The chemoreceptors are typically membrane bound α-helical coiled-coil homodimers 
organized in five domains (Figure 1.6) [50, 99, 108]. The amino-terminal sensing domain is 
responsible for ligand binding, and is flanked by two trans-membrane regions, TM1 and 
TM2. In E. coli, the sensing domain is a four-helix bundle. Ligand binding occurs across the 
dimer interface, and binding-protein interactions occurs on the outer helix [31, 72]. The 
conformation signal is transferred through the HAMP domain (histidine kinase, adenyl 
cyclase, methyl-accepting chemotaxis protein and phosphatase). HAMP domains, usually a 
50-residue relatively conserved motif, are found in many signaling proteins in bacteria and 
archaea. They are thought to converts the signal from sensory input modules to output 
modules. HAMP domains are four α-helices homodimers. In each monomer, there are two 
short amphipathic α-helices (12 –residue of AS-1 and 15-residue of AS-2) joined by a 
flexible connector [7-9, 43]. The signal is transferred to two methylation helices [10, 43, 61, 
108]. This region has conserved glutamate or glutamine residues that can be 
post-translationally modified by CheB and CheR. These modifications have been 
demonstrated to be important during adaptation [36, 54, 86, 114]. Finally, the signal is 
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transferred to the HCD domain (the Highly Conserved Domain, also called as signaling 
domain). The HCD domain interacts with CheA and CheW to control CheA activity [108]. 
There are a number of chemoreceptors allowing bacteria to sense various attractants like 
amino acids and sugars. For example, there are five chemoreceptors in E. coli, and ten 
chemoreceptors in B. subtilis, with size ranging from 35 kDa to 72 kDa [3, 13]. In addition, 
these receptors have been reported to localize to cell poles in both E. coli and B. subtilis [51, 
66, 67]. They are organized in vast arrays that can magnify even the smallest of signals over 
a large concentration range (10-6 to 10-1 M) [34]. In E. coli, the chemoreceptors are believed 
to have a trimer-of-dimers organization based on crystallographic evidence from the 
carboxy-terminal structure of the Tsr receptor [107] and on genetic evidence [6]. However, 
based on recent crystal structure of the carboxy-terminal cytoplasmic region of the 
Thermatoga maritima TM1143 [83], B. subtilis most likely uses “hedgerow of dimers” to 
organize its chemoreceptors (Figure 1.7). 
 
C. Other Chemotaxis Proteins in E. coli   
CheR, a 32 kDa protein, is a methyltransferase placing a methyl group on particular 
glutamate residues via the universal methyl donor S-adenysyl methionine (SAM) [26, 103, 
119]. CheB works as a methylesterase [120, 125]. CheB is also a response regulator that can 
be phosphorylated by CheA. This phosphorylation increases the methylesterase activity of 
CheB by roughly 100 fold, and the activated CheB restores the glutamate residue for 
additional cycles of methylations [104]. Interestingly, the half-life of CheB phosphate is very 
short, less than a second, so that adaptation to negative stimulus is rapid [104]. Both CheR 
and CheB modify conserved glutamate and glutamine residues in the methylation helices 
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MH1 and MH2 of chemoreceptors. These modifications are important to regulate receptor 
conformation, which is important during adaptation, and will be further discussed in Chapter 
5. 
CheW, a 32-kDa scaffold protein, couples CheA to the receptors and relays the 
conformational change signals from chemoreceptors to the downstream HK CheA [71]. The 
CheW null mutants showed no accumulation in capillary assays and a smooth-swimming 
bias in the tethered-cell assays [18, 71, 95]. Therefore, it is an essential bridge in the 
MCP-CheW-CheA complex.  
CheZ, an 18 kDa protein, works as a CheY phosphatase [39]. However, CheZ does not 
exist in most chemotactic bacteria outside of the γ- and β- proteobacteria, such as B. subtilis 
[3, 109]. This will be discussed in more detail in Chapter 5. Bringing CheY-p level to its 
pre-stimulus levels is vital for adaptation, as bacteria need to reset their response to the 
constantly changing environmental conditions. Once getting into a new environment, they 
have to adapt to it and quickly get ready to sense new changes. 
The Flagella Switch is the final output of the chemotactic signal transduction system. It 
controls the motor at the flagellar base, and is responsible for changing directions of flagella 
rotation. In E. coli there are three sub-components in the flagellar switch, including FliM, 
FliN and FliG (Figure 1.8) [49]. Deletion of any above three will prevent flagellar formation, 
indicating that all of these three proteins are essential to motility [122, 123]. After the 
phosphorelay, CheY-p will interact with FliM, and induce a change in the direction of 
flagellar rotation [21]. The switch is a multimeric complex consisting of roughly 35 copies 
each of FliM and FliG and 110 copies of FliN. Note that in B. subtilis FliN is substituted by 
FliY, but the arrangement is assumed to be similar. 
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B. subtilis Chemotactic Sensory Transduction System 
During the last 30 years’ studies, the chemotaxis community has started to realize that E. 
coli might not be the ideal paradigm model for chemotaxis study, mostly because it misses 
several key components found in most other chemotactic organisms. B. subtilis has emerged 
as a more suitable paradigm organism to study bacteria chemotactic signal transduction. Its 
CheA, CheY, CheW, CheB and CheR proteins have similar structures and functions as in E. 
coli [3, 112]. The core of chemotactic signal transduction in B. subtilis is similar to that of E. 
coli: first, MCPs sense ligand signals; then through phosphorelay the HK CheA and CheY is 
phosphorylated, respectively; CheY-p then binds with the switch proteins in the flagellar 
basal body. However, B. subtilis has three unique proteins, CheV, CheC and CheD, which 
are not in E. coli, but found in most other chemotactic bacteria studied to date [3, 112]. B. 
subtilis lacks CheZ, but possesses the flagellar switch protein FliY, a dual-domain protein 
with a CheC-like region and a FliN-like region [3, 111]. All of these made B. subtilis the best 
model to study bacterial chemotactic signal transduction (Figure 1.9). 
CheV, a 35 kDa protein, is the third response regulator in B. subtilis chemotactic 
pathway in addition to CheY and CheB. It has a C-terminal response regulator domain that 
can be phosphorylated by CheA, and an N-terminal CheW-like output domain serving as a 
scaffolding protein for CheA [30, 89]. Both cheW and cheV mutants could still have an 
adequate chemotactic response, however, a cheWcheV double mutant is very tumbly [46]. 
This indicated that either CheW or CheV can mediate signal transferring from MCPs to 
CheA as a scaffolding protein, and they are necessary for the normal MCP-CheA complex. 
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CheD and CheC interact with each other, and both have more than one function.  
They are believed to be more important in chemotactic adaptation, which will be discussed 
in more details in Chapter 4-6. 
 
Scope of This Study 
The main theme of this study focuses on the B. subtilis CheD. The cheD knockout 
mutant shows a chemotactic defect, is less sensitive to attractants, more tumbly, and has 
poorly methylated chemoreceptors, indicating that CheD is an essential protein in B. subtilis 
chemotactic signal transduction [52, 56, 90]. It has been reported that CheD can deamidate 
chemoreceptors as a deamidase [56], and CheD interacts with CheC with unknown functions 
[90, 91].  
The first goal of this work was to characterize CheD enzymatic mechanism as a 
deamidase, and what active sites it has. As described earlier, CheR can methylate 
chemoreceptors on the conserved Glu residues in B. subtilis. In some instances, the modified 
site is encoded as Gln rather than Glu. In order to be methylated, the amine group of Gln 
needs to be removed before it is methylated. K. Kristich has reported that CheD can 
deamidate chemoreceptors, McpA, McpB, and McpC through an unknown mechanism [56]. 
By understanding its enzymatic mechanism, we can further study the relationship of 
deamidation and receptor activation, and how exactly CheD helps tune the downstream 
kinase activation. 
The second goal was to investigate CheD-CheC interaction, whether CheC activates or 
inhibits CheD in terms of CheD deamidase function, and potential sites on CheD that interact 
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with CheC. By this part of study, we can further understand the biological meaning of 
CheD-CheC interaction.  
The third goal was to investigate why CheD-CheC interaction is important in adaptation. 
In detail, we believe that once CheY is phosphorylated, the CheYp-CheC complex will 
attract more CheD from chemoreceptors, which makes receptors less active. This will affect 
the CheA-CheY phosphorelay, bringing the CheYp level back to its pre-stimulus level. To 
verify this hypothesis, I used the Surface Plasmon Resonance (SPR) to exam CheD-CheC 
association/dissociation kinetics under different situations, like without CheY, with CheY, or 
with CheY-P. 
The fourth and final goal of this study was to investigate the interaction between CheD 
and chemoreceptor McpC. McpC, the sole proline receptor, responds to a variety of 
attractants, and is the only CheD-dependent chemoreceptor. It is a good model to study 
receptor-CheD interactions. Addressing how McpC and CheD interact with each other can 
help us understand this special CheD requirement and how CheD makes receptors more 
active. In particular, I mutated the full-length McpC at the AS-1 region of the HAMP domain, 
then screened and tested mutants for potential interaction sites. 
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Figures and Tables 
 
 
 
 
 
Figure 1.1 Bacteria chemotaxis. Bacteria accumulate around a capillary as an attractant 
diffuses out of the capillary opening into the pool of bacteria. This experiment was one of the 
first to show the chemotactic ability of microorganisms.  This figure is a reproduction from 
the original study [92]. 
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Figure 1.2 The two-component systems. The top part shows general schemes of 
two-component systems, and the bottom part shows a basic two-component frame in 
chemotaxis. The two-component pathway is a prevalent control system found in many 
bacteria. The histidine kinase senses an environmental stimulus, causing 
autophosphorylation on a conserved histidine residue. Once excited, the cognate response 
regulator protein associates with the HK and the phosphoryl group is transferred to the RR 
on a conserved aspartate residue. The active, phosphorylated RR then elicits the desired 
response by interacting with it target through the interactions of its output domain. This 
response is often achieved by controlling gene expression. But in bacteria chemotaxis, 
phosphorylated RR will bind with the switch protein in flagella base body to increase the 
CCW rotation. 
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Figure 1.3 Chemotactic response of flagellated bacteria. Flagellated bacteria can move 
towards favorable environment by controlling their flagella rotating. When rotating 
counterclockwise (CCW), due the inherent chirality, the flagella form into a bundle at a pole 
of the cell. Then the cell has a straight and smooth swimming. When rotating clockwise 
(CW), the flagella bundle falls apart, and the cell tumbles. In both swimming and tumbling, 
it is just a matter of ratio of CCW/CW. In an isotropic environment, a bacterium will have a 
55% of CCW rotation (swimming) and 45% CW rotation (tumbling), resulting a random 3-D 
walk and little net migration. When an attractant signal is sensed, the flagella bundle will 
increase the CCW ratio resulting a net swimming towards higher concentrations of attractant 
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Figure 1.4 E. coli Chemotaxis Model. The chemoreceptors interact with an attractant ligand 
in their sensing domain, causing a conformational change that activates the HK CheA, which 
is coupled to the receptors with the aid of the CheW coupling protein.  Once activated, 
CheA transfers its phosphoryl group to the RR CheY, which interacts with the flagellar 
switch proteins. CheY subsequently gets de-phosphorylated with the aid of CheZ. The 
receptors can also get post-translationally modified by the proteins CheR and CheB. 
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Table 1.1 Chemotaxis Proteins 
Protein Activity or Role Comment Structure 
B. subtilis 
   
CheA Histidine kinase Autophosphorylates on 
histidine residue and 
transfers phosphate to 
CheY, CheB or CheV. 
See Figure 1.5 below 
CheB Methyl esterase Demethylates 
methylglutamate 
residues on MCP’s: role 
in adaptation.  Has RR 
domain. 
 
CheC Adaptational 
protein coupling 
with CheD 
 
CheY-P 
phosphatase. 
Role in adaptation.  
 
Shown to bind CheD. 
 
Inhibits CheD 
deamidase activity. 
 
CheD Adaptational 
protein coupling 
with CheC 
 
Glutamine 
deamidase 
Deamidates glutamine 
residues on the MCP’s. 
Makes receptors more 
active. 
Enhances CheC 
phosphatase activity.  
 
CheR  Methyl 
transferase 
Methylates conserved 
glutamate residues on 
MCP’s. 
 
CheV Coupling and 
adaptational 
protein 
CheY-CheW fusion.  
Role in adaptation as 
well as a coupling 
protein. 
No structure available. 
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Table 1.1 cont. 
   
Protein Activity or Role Comment Structure 
CheW Coupling protein Couples CheA to the 
receptors. 
 
CheY Primary response 
regulator 
When phosphorylated, 
interacts with the 
flagella switch to induce 
CCW flagellar rotation. 
 
MCP’s Receptors Bind chemoeffectors 
and transduces signal to 
CheA.  Are methylated 
and demethylated on 
glutamate residues. 
 
Non-B. subtilis 
   
CheX CheY-P 
phosphatase 
Truncated form of CheC 
found in close relatives 
of B. subtilis. 
CheZ CheY-P 
phosphatase 
Hydrolyzes CheY-P in 
the γ- and 
β-proteobacteria, not 
found elsewhere. 
 
(Note: The collection of 3-D structures in this table was from G. Glekas Ph.D. thesis.) 
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Figure 1.5 CheA Architecture. The histidine kinase CheA has five distinct domains (P1-5), 
that each has a separate function as shown in the figure. Crystal structures for certain 
domains have been solved, and are shown above. 
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Figure 1.6 Chemoreceptor architecture. The receptors are long a-helical homodimers with 
five distinct regions, shown above in both a 3-D model of the E. coli Tsr receptor (left) and a 
schematic diagram (right). The sensing domain binds a ligand, inducing a conformational 
change in the receptor that is transmitted through the transmembrane domain to the HAMP 
domain and down into the highly conserved domain (HCD), which interacts with the CheA 
kinase. The methylation domain can be post-translationally modified on conserved glutamine 
and glutamate residues, which makes receptors more or less active. 
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A. 
 
B.  
 
Figure 1.7 Higher order chemoreceptor structure. (A) The crystal packing of both the T. 
maritima and E. coli receptors. (B) The proposed hedgerow model of the chemoreceptor 
signaling array proposed for T. maritima [83].  
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Figure 1.8 The flagellar switch. Electron microscope images of 60 individual S. enterica 
flagella basal bodies [29]. In B. subtilis FliN is substituted by FliY, but the arrangement is 
assumed to be similar. 
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Figure 1.9 B. subtilis chemotaxis model. The chemoreceptors (MCPs) interact with a ligand 
in their extracellular sensing domain, inducing an increase in the level of the HK CheA 
activation. CheA then interacts with the RR CheY, which can bind the flagellar switch, 
causing a change in flagellar rotation. The receptor modifiying enzymes CheB, CheR and 
CheD post-translationally modify conserved residue on MH1 and MH2. CheW and CheV are 
involved in coupling the HK to the chemoreceptor array. CheC and FliY can aid in the rapid 
dephosphorylation of the RR. 
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Chapter 2 
Materials and Methods 
 
Media and Solutions 
Blocking buffer: 20 mM Tris, pH 7.5, 250 mM NaCl, 5% (w/v) milk powder, 0.05% Tween 
20 
Buffer B: 8 M urea, 0.1 M NaH2PO4, 0.01 M Tris, pH 8 
Buffer C: 8 M urea, 0.1 M NaH2PO4, 0.01 M Tris, pH 6.3 
Buffer E: 8 M urea, 0.1 M NaH2PO4, 0.01 M Tris, pH 4.5 
CAMM (Capillary assay minimal media): 50 mM K2HPO4/ KH2PO4, pH 7.0, 1.2 mM 
MgCl2, 0.14 mM CaCl2, 1 mM (NH4)2SO4, 0.01 mM MnCl2, 20 mM sorbitol, 50 µg/ml 
histidine, methionine, and tryptophan 
CAMM+ (Capillary assay minimal media + TBr): 50 mM K2HPO4/ KH2PO4, pH 7.0, 1.2 
mM MgCl2, 0.14 mM CaCl2, 1 mM (NH4)2SO4, 0.01 mM MnCl2, 0.2% (v/v) TBr, 20 mM 
sorbitol, 50 µg/ml histidine, methionine, and tryptophan 
Chemotaxis Buffer: 10 mM K2HPO4/ KH2PO4, pH 7.0, 0.14 mM CaCl2, 0.3 mM 
(NH4)2SO4, 0.1 mM EDTA, 5 mM sodium lactate, 0.05% (v/v) glycerol 
Elution buffer: 50mM NaH2PO4 , 300mM NaCl, 250mM imidazole, pH 8.0 
GEB (Glutathione elution buffer): 50 mM Tris, pH 8.0, 10 mM glutathione 
LB: 1% (w/v) Tryptone, 0.5% (w/v) Yeast extract, 0.5% (w/v) NaCl 
Lysis buffer: 50mM NaH2PO4 , 300mM NaCl, 10mM imidazole, pH 8.0 
PBB (Prescission Protease Buffer) : 100 mM NaCl, 1 mM EDTA, 1 mM DTT, 50 mM Tris, 
pH 8.0 
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Protoplast buffer: 25 mM K2HPO4/ KH2PO4, pH 7.0 20% (w/v) sucrose, 10mM MgCl2, 1 
mM EDTA, 30 mM sodium lactate 
SDS solubilizer buffer (1X): 50 mM Tris, pH6.8, 10% (v/v) glycerol, 5% 
β-mercaptoethanol, 2% SDS 
SPR charging buffer: 0.5 M NiCl2 in SPR running buffer 
SPR regeneration buffer: (I) first round regeneration: 0.35 M EDTA in SPR running buffer 
(II) second round regeneration: 0.1% SDS 
SPR running buffer: TKMD buffer without glycerol 
TBAB: 1% (w/v) Tryptone, 0.3% (w/v) Beef extract, 0.5% (w/v) NaCl, 1.5% Agar 
TBr: 1% (w/v) Tryptone, 0.5% (w/v) NaCl  
TKMD buffer: 50 mM Tris, pH 8.0, 50 mM KCl, 5 mM MgCl2, 0.1 mM dithiothreitol 
(DTT), 10% (v/v) glycerol 
Transfer buffer: 50mM Tris, 40mM Glycine, 0.15mM SDS, 20% (v/v) Methanol 
Wash buffer: 50mM NaH2PO4, 300mM NaCl, 20mM imidazole, pH 8.0 
 
Strains and Plasmids 
 All of the strains and plasmids used in this study are noted in Table 2.1. All of the B. 
subtilis strains are derived from the chemotactic strain (che+) OI1085. All cloning and 
plasmid propagation were performed in E. coli strains TG1. Recombinant protein 
overexpression was done in E. coli strains BL-21 DE3. Plasmids used for protein purification 
were expressed in either pUSH1 or pGEX-6P-2.   
The 6xHis fusion pUSH plasmids that contained the cytoplasmic receptor fragments 
were made by amplifying the carboxy-terminal fragment from OI1085 genomic DNA, or 
 
 
25
from pAIN750 derivatives containing the corresponding receptor, by introducing BamHI 
restriction sites. This resulting fragment was then ligated into the pUSH1 plasmid. The 
pEB112 derivatives for co-expression of the receptor fragment and cheD were made as 
described [56]. Briefly, plasmids containing the receptor and CheD in pEB112 were digested 
with NotI and BamHI, and the 1100 bp fragment that contained the receptor fragment gene 
was ligated into the bigger pEB112 derivative. 
The GST-fusion pGEX-6P-2 plasmids were made by amplifying the desired receptor 
fragment from a pAIN750 plasmid containing the appropriate receptor and mutation by PCR 
and engineering a 5’ EcoRI and 3’ NotI site. This fragment was then ligated into 
pGEX-6P-2.   
All mcpC mutants were created by using Quickchange (Stratagene) mutagenesis on 
pAIN750 variants that contained the full-length receptor gene.  These plasmids were then 
transformed into the amyE locus of the desired B. subtilis background, and selected for 
spectinomycin resistance.   
 
Protein Purification 
 All purified proteins used in this study originated from B. subtilis. The chemoreceptor 
carboxy-terminal fragments used in Chapter 3 were purified as 6xHis-fusions as previously 
described [56]. Both 6xHis-fusion expression plasmids (pUSH1) and the GST-fusion 
expression plasmids (pGEX-6P-2 variants) were expressed in the E. coli BL21 DE3 strain. A 
5 ml Hi-Trap Chelating column or a 5 ml GSTrap columns (GE Healthcare) was used with 
an AKTA Prime FPLC system (GE Healthcare) for purification per manufacturer’s 
instructions.   
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 The 6xHis-McpAc was purified under denaturing conditions. A 6-liter culture of LB 
plus 10 µg/ml chloramphenicol was inoculated 1:100 with an overnight culture of RP3098 
harboring pAIN620 (for the unmodified McpA c-fragment) and grown at 37° C with 
agitation (250 rpm) to an A600nm = 0.8. IPTG was added to 1 mM, incubation was continued 
as before, and cells were harvested by centrifugation at 5000 x g for 5 min after 3 h. Cell 
pellets were frozen at -80 °C. Thawed cell pellets were resuspended in Buffer B and 
incubated at room temperature for 1 h with mixing. The supernatants were clarified by two 
serial centrifugations (7000 x g, 5 min; 40,000 x g, 40 min) and loaded onto the Ni-charged 
Hi-Trap column. The column was washed with 10 volumes Buffer B, followed by 10 washes 
with Buffer C. Elution was performed with 25 mL Buffer E. These samples were dialyzed 
against three changes of 25 mM NH4HCO3 at 4 °C, and aliquots were frozen at -80° C. 
 To purify the GST-fusion proteins, pGEX-6P-2 with the assorted chemotaxis 
proteins was cloned in the multiple cloning site. A saturated overnight culture was diluted 
1:100 into three of 2 liters LB with 100 µg/ml ampicillin and grown at 37 °C (250 rpm) to 
A600 of 0.6. IPTG was then added to 1 mM. GST-CheC, GST-6xHis-CheD, and GST-CheA 
cultures were incubated at 200 rpm overnight at room temperature, and GST-CheY culture 
was incubated at at 15°C (200 rpm) for 3 days. Cells were spinned down at 8,000 x g, 8 min 
and frozen for storage. Thawed cell pellets were resuspended in PBS (pH 7.3) buffer 
followed by sonication. The supernatants were clarified by two rounds of centrifugations 
(9,000 x g, 15 min; 65,000 x g, 40 min), and applied to 5-ml GSTrap columns pre-washed 
with 10 column volumes of PBS buffer. Protein bound columns were then washed with at 
least 15 column volumes of PBS buffer, and GST tagged proteins was eluted with using 10 
ml of elution buffer (50 mM Tris, 5 mM glutathione, pH 8). To remove the GST tag, the 
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purified GST-CheC or GST-CheY was cleaved by PreScission protease, as specified by the 
supplier (Amersham Biosciences), and applied to another 5 ml GSTrap column. The 
flow-through was collected and concentrated to ~5 ml using a cellulose ultrafiltration 
membrane (Millipore) in an Amicon ultrafiltration cell. Then the purified proteins were 
dialyzed in TKMD buffer without glycerol and aliquots were stored at -80°C. 
The cell lysate was then passed through a 5 ml GSTrap column (GE Healthcare) and 
washed with at least 5 bed volumes of TBS. The fusion proteins were eluted from the 
column with 20 ml GEB. This was dialyzed against six changes of 800 ml PPB. The GST tag 
was removed by digestion with 100 units of PreScission protease for 12 h at 4°C. This 
solution was again passed over the GSTrap column to remove the GST and protease. The 
pure Che protein flow-through was collected and dialyzed against four changes of 1 L 
TKMD and then stored at -80°C. 
 
Western Blot Sample Preparation 
Bacterial strains that were used for quantitative western blot analysis (∆10 
background strains in this study) were streaked out on TBAB plates and incubated overnight 
at 30°C. Colonies from this plate were used to start a 50 ml CAMM+ culture with an initial 
A600nm = 0.02. Cells were then incubated at 37°C with aeration until reaching 
mid-exponential phase (approximately 10 hrs.). Cells were then diluted 1:10 (v/v) into 50 
mls CAMM, then put back in the incubator until reaching mid-exponential phase 
(approximately 10 hrs.). Cells were then diluted with CAMM to A600nm = 0.01 and were 
incubated until they reached mid-exponential phase (approximately 14hrs.). The culture was 
then diluted 1:10 (v/v) with CAMM into multiple flasks (to a total volume of 50 ml) and 
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were returned to the incubator until they reached A600nm = 0.6. Cells were then pelleted. The 
pellet was then washed once with 5 ml of Protoplast buffer and diluted to A600nm = 1 in 10 ml 
Protoplast buffer with 250 g/ml chloramphenicol and 4 mg/ml lysozyme and incubated at 
37°C for 30 min. Protoplasts were collected by centrifugation and resuspended in 500 µl of 
SDS solublizer buffer (1X). The number of cells loaded per pane of SDS-PAGE was 
5.2E+07 cells per lane. 
 
Western Blot  
     Samples were separated by SDS-PAGE and then transferred to PDVF membrane 
(Millipore) by semi-dry transfer. Membrane was blocked for 4 h with Blocking buffer; then 
the primary antibody was added for overnight incubation.  Dilutions for primary antibodies 
were: 1:20,000 anti-McpAc, 1:400 anti-CheD. The membranes were then washed with water 
at least four times. Then they were incubated with a 1:20000 dilution of the secondary 
antibody (HRP-conjugated goat-anti-rabbit-IgG, Pierce) in Blocking buffer for 2 h. 
Membranes were again washed four times with water and then treated with ECL Plus signal 
solution as per the manufacturer’s specifications (GE Healthcare). Visualization was 
achieved via LabWork photostation. Bands were quantified with LabWork software or 
ImageQuant software. 
 
Receptor Deamidation Assay 
Deamidation reactions were performed as previously described [56]. Briefly, 1 µM of 
McpA c-fragment was incubated with equal concentration of CheD or mutated CheD at 
room temperature in reaction buffer (50 mM Tris, pH 7.5, 0.1 mM dithiothreitol, 1 mM MgCl2, 
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0.5 mM EDTA). At the indicated times, samples (10 µl) were removed and mixed with 10 µl 
of 2× SDS loading buffer. Immunoblotting was performed as described above. To investigate 
CheC’s inhibition, 2 µM of CheC and 2 µM of CheD were used in the incubation of McpAc.  
 
Swarm Plate Assay 
The swarm plate assay allowed for quick characterization of an overall chemotactic 
phenotype comparing to a wild type strain and was performed as described [57, 56]. In this 
study, proline swarm plates were used to identify cheD or mcpC mutants’ phenotypes. 
Briefly, strains were grown on a TBAB plate at 30ºC for 16 h. Individual colonies were 
spotted onto low nutrient low agar swarm plates (0.2 mM proline, 0.1x Spizizen’s salts, 
0.7mM sorbitol, 5 µg/ml required amino acids, 0.25% agar) and incubated at 37ºC for 10 h. 
As the bacteria metabolized the nutrient, they started swimming outwards and created an 
attractant gradient. This behavior led to the formation of a characteristic ring. The diameter 
of the ring was measured and compared with the wild type strain, which was present on each 
swarm plate as a positive control. All strains were observed in at least three duplicate plates. 
 
Tryptic Digestion and HPLC Peptide Separation 
 50 µM of CheD was incubated with 1 mM of dansyl fluoride (DNSF) at room 
temperature for 30 min. Then the DNSF was removed by passing through the Sephadex™ 
G-25 column as per the manufacturer’s specifications (GE Healthcare). Purified CheD was 
then digested in approximately a 25:1 molar ratio of protein to trypsin for 24 hours at 37oC. 
Samples were then injected into a Shimadzu VP Series HPLC, incorporating a Waters 
Symmetry 300 Reversed Phase C18 column, and running Shimadzu VP-EZStart software, 
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which was subsequently used for all HPLC analysis. A 0-55% gradient of water:acetonitrile, 
both with 0.1% trifluoroacetic acid, run over 45 min, at 1 ml/min and 35o C, was used to 
elute tryptic peptides. Peptides were visualized with a UV detector set at 220 nm. Peaks were 
collected and sent for MS/MS analysis, which was performed at the UIUC Center for 
Top-Down Proteomics under the direction of Andy Forbes. 
 
Surface Plasmon Resonance (SPR) 
SPR is a good tool to study protein-protein interaction. In addition to KD, we can also 
measure the binding and dissociation kinetics by SPR. In this study SPR was performed 
using the Biacore 3000 system and NTA sensorchips (GE Health). The sensorchip was 
activated according to the manufacturer’s instructions, and the buffers used in the 
microfluidic system were as follows: running buffer (TKMD without glycerol), regeneration 
buffer (0.35 M EDTA in running buffer), and nickel solution (0.5 M NiCl2 in running buffer). 
The flow rate 20 µl/min was used through all experiments.  
The chip was pre-cleaned by injection of 20 µl regeneration buffer I and II, and then 
charged by 20 µl of nickel solution. 20µl of 0.1% BSA was then injected to remove 
background binding. Then 500 response units (RU) of GST-6xHis-CheD was immobilized 
on three different flow cells (2, 3, and 4), while the flow cell 1 was used as a mock 
immobilized, blank control. After immobilization, 80 µl of CheC at different concentration 
was injected, respectively, to study CheD-CheC binding kinetics.  
To study CheD-CheC-CheY binding kinetics, different from the above, 20 µM of CheY 
in TKMD (without glycerol) was used as the running buffer and through all the experiment. 
During injection of CheC, the same concentration of CheY was also added.  
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Similarly, to study CheD-CheC-CheYp binding kinetics, 5 mM of acetyl phosphate and 
20 µM of CheY in TKMD (without glycerol) was used as the running buffer. The same 
concentrations of Ace-P and CheY were also added while injecting CheC.  
After each round of binding and dissociation, the NTA chip was regenerated and 
charged again for the next round of study. The SPR curves were then processed and analyzed 
using BIAevaluation software as per the manufacturer’s specifications (GE Healthcare). 
 
SPR Data Analysis 
 Sensorgram base lines were normalized to zero response units (RU) prior to analysis. 
Samples were run over mock-derivatized flow cell 1 to determine background RU values due 
to bulk refractive index differences between solutions. SPR data were globally fit to a 1:1 
Langmuir binding model: 
                                                       (1) 
In this equation, [A] is the concentration of analyte CheC injected, and [B] is the 
immobilized ligand GST-6xHis-CheD. 
Because the biosensor data did not fit to a simple 1:1 model (the derivatives of the 
binding response and the dissociation were nonlinear), the binding data were evaluated by 
linear transformation analysis [23, 97]. For a simple bimolecular interaction (Equation 1), the 
dissociation and association process are described, respectively, as: 
RU = RU0 e(-koff t)                     (2) 
and 
             (3) 
In these equations, kon and koff are the association and dissociation constants, 
respectively; RU is the relative response at time t, and is proportional to the amount of the 
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AB complex formed (CheC-CheD complex in this case); RUmax denotes the amount of ligand 
CheD immobilized on chip; and RU0 is the response at the beginning of the dissociation. 
For a single exponential process (Equation 2), a plot of ln(RU) vs time will yield a 
straight line with a slope of –koff. For Equation 3, set ks = - (kon[A] + koff). By plotting 
dRU/dt vs RU, ks (the slope) was determined. With the previously calculated koff and a known 
[A] value, kon was then calculated. The equilibrium dissociation constant (KD) was calculated 
from the equation KD = koff/kon. 
 
Structural Modeling 
 Structural modeling was performed on CheD, CheC, and the HAMP domain of McpC 
using the SWISS-MODEL modeling server [12, 48, 85]. Related sequences were submitted, 
and the resulting PDB files were consequently studied using PyMol or VMD softwares [44]. 
WinCoot software was used to superimpose related protein structures from different species 
in order to see any potential difference. 
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Tables 
Table 2.1 Strains and plasmids used in this study 
        
 Relevant genotype or description Reference 
 
OI1085 Che+, trpF7 hisH2 metC133 [116] 
OI2934 cheD1::cat [90] 
OI3135 ∆cheC1 [90] 
OI3280 mcpC4::erm  [79] 
OI3545 ∆10mcp che+  [56] 
OI3628 ∆10mcp cheD1::cat  [56] 
OI3932 OI3545 amyE5720::mcpB [56] 
OI4007 OI3545 amyE5720::mcpC [56] 
OI4438 OI3545 amyE5720::mcpC Q304A This work 
OI4439 OI3545 amyE5720::mcpC Q305A This work 
OI4440 OI3545 amyE5720::mcpC P302A This work 
OI4441 OI3545 amyE5720::mcpC K309A This work 
OI4442 OI3545 amyE5720::mcpC T310A This work 
OI4443 OI3545 amyE5720::mcpC K311A This work 
BL21(DE3) Escherichia coli protease deficient expression host Novagen 
TG1 E. coli cloning host Amersham 
 
pBluescriptSK- E. coli cloning vector, AmpR Stratagene 
pGEX-6P-2 E. coli GST-tag expression vector, AmpR Amersham 
pDR67 amyE integration plasmid, pSpac, AmpR, CmR [45] 
pUSH1 B. subtilis-E. coli shuttle vector for His-tag fusions [98] 
pAIN620 pUSH1 expressing His6-tagged-McpA cytoplasmic domain [56] 
pUSH1 B. subtilis-E. coli shuttle vector for His-tag fusions [98] 
pHS101 pGEX-6P-2::cheA1 [109] 
pHS102 pGEX-6P-2::cheY1 [109] 
pTM18 pGEX-6P-2::cheC2 [111] 
pTM25 pGEX-6P-2::cheD2 [111] 
pWY12 pGEX-6P-2::cheD2 (S32A) This work 
pWY13 pGEX-6P-2::cheD2 (C33A) This work 
pWY17 pGEX-6P-2::cheD2 (H50A) This work 
pWY19 pGEX-6P-2::cheD2 (D40A) This work 
pWY62 pGEX-6P-2::cheD2 (T27A)  This work 
pWY65 pGEX-6P-2::cheD2 (K68A)  This work 
pWY66 pGEX-6P-2::cheD2 (R157A) This work 
pWY88 pGEX-6P-2::6xHis-cheD2 This work 
pWY69 pGEX-6P-2::cheD2 (C86S C152S)  This work 
pWY72 pGEX-6P-2::cheD2 (C86A C152A)  This work 
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Table 2.1 cont. 
   
 
pWY74 pGEX-6P-2::cheD2 (N65A) This work 
pWY75 pGEX-6P-2::cheD2 (K68R) This work 
pWY76 pGEX-6P-2::cheD2 (D71A) This work 
pWY77 pGEX-6P-2::cheD2 (K122L) This work 
pWY78 pGEX-6P-2::cheD2 (T144R) This work 
pWY79 pGEX-6P-2::cheD2 (M101A) This work 
pWY80 pGEX-6P-2::cheD2 (M101E) This work 
pWY81 pGEX-6P-2::cheD2 (F102A) This work 
pEB112 B. subtilis-E. coli shuttle vector; KanR AmpR [60] 
pWN5 pEB112 containing cheD; KanR AmpR [60] 
pWY22 pEB112::cheD2 (S32A) This work 
pWY23 pEB112::cheD2 (C33S) This work 
pWY24 pEB112::cheD2 (C33A) This work 
pWY25 pEB112::cheD2 (D40A) This work 
pWY26 pEB112::cheD2 (H50A) This work 
pWY25 pEB112::cheD2 (D40A) This work 
pWY63 pEB112::cheD2 (T27A) This work 
pWY16 pEB112::cheD2 (S32C) This work 
pWY18 pEB112::cheD2 (S56C)) This work 
pWY20 pEB112::cheD2 (S134C) This work 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
35
Chapter 3  
CheD is a Cysteine Hydrolase 
 
Introduction 
CheD, an 18 KDa protein, is one of the unique chemotaxis proteins that do not exist in 
E. coli. The cheD knockout mutant shows a chemotactic defect in every assay in which they 
were tested, which indicates that CheD must play important roles in chemotaxis [52, 56, 91].  
As described in Chapter 1, CheR can methylate chemoreceptors on the conserved Glu 
residues in B. subtilis [38, 129]. In some instances, the modified site is encoded as Gln rather 
than Glu. In order to be methylated, the amine group of Gln needs to be removed before it is 
methylated. In E. coli, this deamidation is carried out by CheB through a serine hydrolase 
mechanism, then subject to cycles of reversible methylation [47]. In B. subtilis, K. Kristich 
has reported that CheD can deamidate chemoreceptors, McpA, McpB, and McpC [56]. 
Specifically, in K. Kristich’s work he incubated McpAc-term with CheD in vitro. After 
immunoblot assays, band shifts were found. By peptide sequencing it turned out that the 
band shifting were due to deamidation of McpAc-term. Meanwhile, V. Cannistraro also 
found that CheD can deamidate the soluble receptor YfmS (V. Cannistraro Ph.D. thesis). 
But the enzymatic mechanism of this deamidation was still unknown. The focus of this 
chapter is on the identification of CheD enzymatic mechanism as a deamidase.  
 
Putative CheD Active Site Mutations Show a Chemotactic Defect 
In order to verify CheD active sites, the sequence of CheD in B. subtilis was aligned 
with CheD from 17 other related species. Some 100% conserved residues were 
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point-mutated into Ala, including Thr27, Ser 32, Cys33, Asp40, and His50 (Figure 3.1). 
Those pEB112 derived plasmids containing mutated cheD were transformed into the cheD 
null strain. The mutants were then analyzed on swarm plates, and examined whether these 
mutants could form chemotactic rings towards proline.  
 From the swarm plate assay, the cheD complemented strain was capable of supporting 
chemotactic ring formation, whereas the cheD-null strain could not. Interestingly, Ser32, 
Cys33, His50, Thr27, and Asp40 mutants did not form a clear chemotactic ring, and only 
diffused within a small region as cheD-null did (Figure 3.2 A and B). Therefore, these sites 
are essential for the normal CheD function, and some of them can be within CheD active 
sites. Other mutated strains like cheD(S56C) or cheD(S134C) could still swim as the positive 
control (data not shown). 
To make sure that these mutated CheD proteins could be expressed in vivo, strains were 
grown under minimum media as described in Chapter 2. The cell lysates were then 
immunobloted against the anti-CheD antibody. Results showed that these mutated CheD’s 
could be expressed in vivo (Figure 3.3). 
 
Putative CheD Active Site Mutations Show a Deamidase Defect 
The swarm plate assay showed overall phenotypes of cheD mutants. In order to verify 
their effects on CheD deamidation, the above mutated cheD’s were subcloned into 
pGEX-6p-2 vector for protein expression. After protein purifications, receptor deamidation 
assays were performed by incubating McpAc-term with equal concentrations of CheD or 
mutated CheD, respectively. 
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The immunoblot results showed that there was no deamidation for mutated CheD’s 
Cys33, Thr27, His 50, Ser28, and Asp40 (Figure 3.4), which indicated that these sites are 
possibly in the active sites, or related to receptor binding, or maintain the normal CheD 
structure. 
 
CheD is Not a Serine Hydrolase 
Both Ser32 and Cys33 are 100% conserved residues. CheD can possibly be a serine or 
cysteine hydrolase. To test if it is a serine hydrolase, I used a serine protease inhibitor, dansyl 
fluoride (DNSF). DNSF is a small ser-type suicide inhibitor, which covalently binds to the 
serine active site of enzymes. After incubation of GST-CheD with or without DNSF, DNSF 
was removed by passing through Sephadex™ G-25 protein desalting column to prevent 
impairing subsequent digestion by trypsin. Then proteins were digested by trypsin in solution 
followed by rp-HPLC purification. By comparing the spectrum difference, I picked up vial 
#72 from the DNSF+ elution samples, which did not appear in DNSF- elution spectrum. 
DNSF is a fluorescent inhibitor that can be monitored at A360. A peak was detected at 
Vial#72 position under A360 monitoring (Figure 3.5 A). Vial#72 was then sent for tandem 
MS Spec peptide sequencing.  
From the tryptic digestion spectrum of GST-CheD, Ser32 should be in the peptide of 
TSGLGSCVGLVLYDK (position 254-268). But the MS Spec results showed that the 
selected peptide is EQLSLFNIPIISEDTGGSSGR (position 350-370) (Figure 3.5 B). This 
result indicated that CheD is not likely a serine protease, because the DNS derivatizing site is 
not in the proposed peptide. If Ser32 were the active site, it should have much more readily 
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formed a DNS adduct than any other Ser residues in EQLSLFNIPIISEDTGGSSGR, and 
gave us a stronger signal during HPLC elution. 
 
Structural Modeling Analysis of CheD 
The Crane lab successfully obtained CheC-CheD co-crystal structure from T. maritime 
(2.5Å, R factor 21%) [24], which greatly helps us to better understand CheD functions 
(Figure 3.6). Structure homology modeling was performed to get CheD structure in B. 
subtilis (Figure 3.7). The structure was obtained from SWISS-MODEL database, and was 
based on the template 2f9z, the same structure that the Crane lab got (Sequence identity: 
38%). From the structure, B. subtilis CheD has a three-fold α/β/β sandwich-like structure. 
To see how much CheD structures from B. subtilis and T. maritime overlap with each 
other, two structures were superimposed with using WinCoot software and viewed in PyMol 
software (Figure 3.8). From the superimposed structure, the two CheD structures overlay 
very well (Core rmsd achieved: 0.310487Ả). The only notable difference may be the TNDL 
loop (107-110 in B. subtilis), which is extended further in space comparing with CheD in T. 
maritime. Overall, CheD structure from the Crane lab is a very good starting model to study 
CheD structure in B. subtilis.  
When enlarging the CheC-CheD interaction area, we can see that Cys33 is closer to 
His50 and Thr27 compared with Ser32, and is more likely to be in the active site. And Asp40 
is located at the end of в-sheet far away from the active site, and is unlikely in the active site 
(Figure 3.9). Cys33-His50-Thr27 is likely to be the catalytic triad of CheD through a 
cysteine hydrolase mechanism. 
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Cysteine Protease Inhibitors Stop CheD Deamidation 
To further verify that CheD is through a cysteine hydrolase mechanism, a CheD double 
mutation (D86152) was made by mutating Cys86 and Cys152 into Ala. In this mutant, Cys33 
is the only cysteine in CheD.  
The purified D86152 were then used in the receptor deamidation assay. In this case, 
McpAc-term was incubated with D86152 and with or without cysteine protease inhibitors 
followed by anti-McpA immunoblot. Two cysteine proteases that were used are 
n-ethylmaleimide (NEM) and iodoacetamide (IA). The results showed that D86152 could 
still deamidate receptor, albeit its deamidase activity was lower than the wild-type CheD 
from a separate assay (data not shown). After two above cys inhibitors were added, 
respectively, the deamidations were stopped (Figure 3.10). It indicated that CheD is most 
likely to be a cysteine hydrolase. 
 
Ser32 is Responsible for Receptor Binding 
Previous data have shown that both Cys33 and Ser32 mutant had no deamidase activity. 
Although Cys33 is most likely to be in the active site based on the last section’s result, 
unanswered questions still remain, “what is Ser32 function?” and “why did Ser32A mutant 
show no deamidation”? 
To address these questions, the GST pulldown assay followed by immunoblot was 
performed. In this assay, McpAc-term was incubated with wild-type GST-CheD or 
GST-CheD mutants (S32A or C33A) with presence of glutathione beads. The anti-McpA 
antibody was used in the following western blot. The immunoblot result showed that 
GST-CheD could pull down McpAc-term (where the signal had to be amplified by western 
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blot); GST-CheD (S32A) had no McpAc-term binding signal; and C33A mutations would 
not influence McpAc-term binding (Figure 3.11). These interesting results indicated that 
Ser32 is most likely plays an important role in receptor binding, and Cys33 is the in the 
active site. Since S32A mutation destroyed CheD-McpA binding, it is therefore reasonable 
that the enzyme became inactive. 
 
Discussion 
It has been reported that CheD deamidates 'Gln-593' and 'Gln-594' of the chemoreceptor 
McpA, and deamidates other chemoreceptors including McpB and McpC [56]. Additionally, 
CheD is required for the generation of wild-type prestimulus CheA autophosphorylation 
levels shown by the cheD null phenotypes [56, 90]. Elucidating of CheD deamidase 
mechanism can potentially help us understand CheD’s role better, especially how CheD 
makes chemoreceptors more active.  
Originally, we thought CheD’s deamidase activity is through a serine hydrolase 
mechanism, which usually has a Ser-Asp-His catalytic triad. It was based on two facts: (a) 
CheB, which deamidates receptors in E. coli, is through a serine hydrolase mechanism [47]; 
(b) Ser32 is a 100% conserved residue, which indicates that it may be essential to CheD’s 
function.  
Indeed, cheD(Ser32A) mutation did not show deamidation bands in the receptor 
deamidation assay (Figure 3.4 A), and cheD(Ser32A) did not swim well on proline swarm 
plates (Figure 3.3 A). But other mutations including Cys33A, His50A, Thr27A, and Asp40A 
caused similar phenotypes (Figure 3.3 and 3.4). It is possible that these sites are in the 
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deamidase active sites, or related to CheD-receptor interaction, or important to maintain the 
normal CheD structure. 
To further investigate CheD active sites, a series of experiments were performed. I 
firstly tested effect on CheD of serine protease inhibitors, like DNSF and AEBSF. Both 
inhibitors are small suicide inhibitors that derivatize the serine residue of serine proteases. 
With addition either of these two inhibitors, CheD deamidase activity was stopped (data not 
shown). In addition, AEBSF seems to unspecifically derivatize McpAc-term as it caused 
faster migration on SDS-PAGE gel. The deamidated receptors should migrate slower in gel. 
Therefore, AEBSF is not a good inhibitor in this case.  
To get direct evidence of DNSF derivatization, GST-CheD was incubated with DNSF 
followed by removal of DNSF, tryptic digestion, reverse phase-HPLC separation, and 
tandem MS-Spec peptide sequencing. If Ser32 were in the active site, DNS should derivatize 
it and be detected by tandem MS-Spec peptide sequencing. But the result showed that no 
Ser32-containing peptide was detected. Instead, another peptide (position 350-370) was 
derivatized (Figure 3.3). Therefore, CheD is unlikely to be a serine hydrolase. Otherwise, the 
peptide containing Ser32 should have been the most likely to have been derivatized. 
With emergence of the CheC-CheD co-crystal structure from the Crane lab, we had a 
better tool to understand CheD’s mechanism and functions [24]. CheD of B. subtilis overlays 
that of T. maritime very well, except that the TNDL loop (position: 107-110) is more 
extended in B. subtilis (Figure 3.8). Therefore, the CheD structure from T. maritime is a very 
sound template to study CheD from B. subtilis.  
From the CheD structure, we can see that Ser32 is farther away from His50 and Thr27 
center compared to Cys33 (Figure 3.9). B. Crane proposed that CheD resembles a class of 
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bacterial toxins represented by the cytotoxic necrotizing factor 1 (CNF1) [22, 24]. CNF1 
causes alteration of the host cell actin cytoskeleton and promotes bacterial invasion of 
blood-brain barrier endothelial cells. CNF1 also has a three-layered α/β/β sandwich-like 
structure. The position of the catalytic Cys residue is located at the base of a deep pocket 
restricting access to potential substrates, which can bring the high specificity of binding to 
target proteins. The putative active site of CheD in B. subtilis is also surrounded by α helices, 
β sheets, and an extended loop. Additionally, B. Crane thought that CheD also resembles a 
class of proteins of unknown function represented by YfiH from B. subtilis (Figure 3.12). 
CheD, CNF1, and YfiH have common topologies with an α/β/β sandwich core surrounded 
by different peripheral loops. They all have Cys-His in the catalytic triad, while the third 
active residue varies. The coordinates of the CheD putative active site is closer to CNF1. In 
fact, the coordinates of the CheD active site in B. subtilis is also similar to that in T. maritima 
(Figure 3.13). 
To get the direct evidence that CheD is a Cys-type hydrolase, I did two more 
experiments. First, I made CheD (C86A C152A) double mutant and purified the protein. 
There are only three Cys residues in wild-type CheD. By mutating other two Cys (positioned 
at 86 and 152) into Ala, the potential alternative derivatizing sites was removed. 
Theoretically, only Cys33 can derivatize with a cysteine protease inhibitor if CheD is a 
cysteine hydrolase. Then the mutated protein was used in receptor deamidation assay with or 
without cysteine protease inhibitors like NEM or IA. Indeed, both NEM and IA stopped its 
deamidation. Therefore, CheD is most like a cysteine hydrolase.  
Furthermore, it turns out that S32 plays an important role in receptor recognition and 
binding (Figure 3.11). Once mutated into Ala, CheD will be no longer able to interact with 
 
 
43
receptors. That is why CheD (S32A) showed a defect in deamidation. In addition, CheD 
(D40A) also showed deamidation defect. The reason is still unknown. Asp40 is located at the 
end of a β sheet, far away from the active center. The defect on deamidation could possibly 
due to the need for Asp40 to maintain the normal CheD structure, so that cheD(Asp40A) was 
unable to function as a deamidase. 
Like most other cysteine proteases, CheD involves a nucleophilic cysteine thiol in the 
catalytic triad. The first step is deprotonation of Cys27’s thiol group by adjacent His50 with 
a basic side chain. Next, the deprotonated cysteine’s anionic sulfur will take nucleophilic 
attack on the substrate carbonyl carbon (receptor). Thr27 would polarize and stabilize the 
whole catalytic triad intermediate structure. After a fragment of substrate with an amino 
terminus is released, the thioester intermediate is formed linking the Cys27 thiol to the new 
carboxy-terminus of the substrate. Next, the thioester bond is hydrolyzed to release the 
remaining substrate fragment. Meanwhile, the free Cys hydrolase, CheD, is regenerated for 
the next round of digestion (Figure 3.14). 
Overall, CheD deamidase activity is through a cysteine hydrolase mechanism, instead 
of a serine protease mechanism. The catalytic triad consists of Cys33-His50-Thr27. And 
Ser32 is essential for receptor recognition and binding. We may further study the relationship 
of deamidation and receptor activation, and how exactly CheD helps tune the downstream 
kinase activation. 
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Figures and Tables 
 
 
Figure 3.1 Sequence alignments of CheD from B. subtilis and 17 other species. The 
alignment was performed with Clustal X. CheD putative active sites (T27-C33-H50) and S32 
were boxed in black. Species abbreviations: Aful, Archaeoglobus fulgidis; Atum, 
Agrobacterium tumefaciens; Bbur, Borrelia burgdorferi; Bhol, Bacillus halodurans; Bsub, 
Bacillus subtilis; Cace, Clostridium acetobutylicum; Ccre, Caulobacter crescentus; Cthe, 
Clostridium thermocellum; Dhaf, Desulfitobacterium hafniense; Neur, Nitrosomonas 
europaea; Oihe, Oceanobacillus iheyensis; Paer, Pseudomonas aeruginosa; Phor, 
Pyrococcus horikoshii; Rsph, Rhodobacter sphaeroides; Smel, Sinorhizobium meliloti; Tmar, 
Thermotoga maritime; Tten, Thermoanaerobacter tengcongensis; Xcam, Xanthomonas 
campestris. 
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Figure 3.2 Swarm plate screening of putative CheD active site mutants. Strains contain 
pEB112 derived plasmids with mutated cheD in cheD-null background. Swarm plates were 
composed of minimal medium supplemented with proline as the attractant. All strains were 
assayed a minimum of four independent times. Results from a representative experiment are 
shown. The image was processed using LabWork to maximize contrast. (A) cheD S32A, 
D40A, H50A, and C33A mutants. (B) cheD T27A mutant. Strain analyzed are: (1) cheD-null, 
negative control; (2) cheD complemented strain, positive control; (3) cheD (S32A) in 
cheD-null; (4) cheD (D40A) in cheD-null; (5) cheD (H50A) in cheD-null; (6) cheD (C33A) 
in cheD-null; (7) cheD (T27A) in cheD-null. 
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Figure 3.3 In vivo protein expression assays of cheD putative active site mutants. Strains 
contain pEB112 derived plasmids with mutated cheD were grown as described in Chapter 2, 
then immunobloted with anti-CheD.  
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Figure 3.4 Receptor deamidation assays with CheD and its putative active site mutants. 
All reactions contained 1 µM of McpAc-term and equal concentrations of CheD or mutated 
CheD. Samples were incubated at RT for 1 hr, and reactions were terminated by addition of 
2x SDS loading buffer.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
McpAc    +CheD   +S32A    +D40A   +H50A   +C33A   
McpAc       +CheD      +T27A
A 
B 
 
 
48
 
W e i # 6 3 -9 2 R T : 9 .2 0 -9 .9 0 A V : 1 7 N L : 7 .2 3 E 1
F : IT M S  +  p  E S I F u ll m s 2  8 8 2 .8 0 @ c id 3 5 .0 0  [2 4 0 .0 0 -2 0 0 0 .0 0 ]
4 0 0 6 0 0 8 0 0 1 0 0 0 1 2 0 0 1 4 0 0 1 6 0 0
m /z
0
1 0
2 0
3 0
4 0
5 0
6 0
7 0
8 0
9 0
1 0 0
R
el
at
iv
e 
A
bu
nd
an
ce
1 2 7 5 .5 8 3
9 5 2 .3 3 3
4 8 8 .0 8 3 1 0 6 5 .4 1 73 7 5 .0 8 3 8 1 1 .3 3 3
6 3 8 .2 5 0
1 1 7 8 .5 0 0 1 3 8 8 .5 8 3 1 5 0 2 .6 6 7
A
B
Intact mass = 1761.895 Da (monoisotopic mass)
EQLSLFNIPIISEDTGGSSG R
w/o DNSF
with DNSF
OD360
 
 
Figure 3.5 HPLC and tandem MS spec analysis of tryptic digested GST-CheD with or 
without DNSF. (A) Separation of tryptic digested CheD with or without DNSF by rp-HPLC. 
(B) Tandem MS spec results of the selected peptide peak from (A).  
 
 
 
 
 
 
 
49
 
 
 
 
 
 
 
 
 
CheD CheC
 
 
Figure 3.6 CheD-CheC cocrystal structure (T. maritima). The 3-D structure was 
regenerated with VMD based on the Crane lab work [24].   
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Figure 3.7 Structure modeling of B. subtilis CheD. The 3-D structure of B. subtilis CheD 
was obtained from SWISS-MODEL database, 
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Figure 3.8 Superimposing of CheD structure from B. subtilis and T. maritima. The 3-D 
structure of B. subtilis CheD was obtained from SWISS-MODEL database, and then 
superimposed by WinCoot software. The red color represents CheD from B. subtilis, and the 
cyan color represents CheD from Thermotoga maritima.  
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Figure 3.9 Structure of CheD putative active sites. Only CheC-CheD interaction area was 
shown. From the structure, C33 is closer to H50 and T27 comparing with S32, and is more 
likely to be in the active site. 
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McpAc           +D86152     +D86152+NEM    +D86152+IA 
 
Figure 3.10 Immunoblot of receptor deamidation assay with cysteine protease 
inhibitors. Two cysteine protease inhibitors that were used are N-ethylmaleimide (NEM) 
and iodoacetamide (IA). D86152 represents CheD (C86A C152A) mutant removing all other 
Cys sites except C33 in CheD. Anti-McpA antibody was used to detect modifications. 
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Figure 3.11 Binding of McpAc-term and GST-CheD and its mutants by pulldown assay 
followed by immunoblot. Equal concentrations of GST-CheD or its mutants were incubated 
with McpAc-term using glutathione beads. After pulldown assay, anti-McpA antibody was 
used in the following immunoblot. Lane 1: McpAc-term + GST-CheD; lane 2: McpAc-term 
+ GST-CheD (S32A); lane 3: McpAc-term + GST-CheD (C33A); lane 4: GST-CheD only; 
lane 5: McpAc-term alone without incubating with glutathione beads (M.W. marker). 
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Figure 3.12 The structures of CheD, CNF1 catalytic domain, and 1XAF. Folds and 
active site structures for (A) CheD, (B) CNF1 catalytic domain, and (C) Shigella flexneri 
YfiH. The three classes of proteins have common topologies (analogous regions in orange) 
but different peripheral loops and inserted regions (gray). CheD and CNF1 have similar 
active sites; YfiH incorporates an additional His ligand that allows zinc coordination. This 
figure is from B. Crane’s published paper [24].  
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Cys33                   His50               Thr27 
 
Figure 3.13 3-D coordinates of CheD active site in B. subtilis. The catalytic triad 
(Cys33-His50-Thr27) was viewed and drawn by PyMol software. 
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Figure 3.14 The cysteine protease mechanism. The picture was from 
http://en.wikipedia.org/wiki/File:Cysteinprotease_Reaktionsmechanismus.svg. 
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Chapter 4 
CheC Inhibits CheD Deamidase Activity 
 
Introduction 
When the present study was initiated, we knew that CheD interacts with CheC, but the 
physiological significance of this interaction was unknown [91]. Since the cheD null mutant 
showed a chemotaxis defect, CheD was thought to be important for chemotactic signal 
transduction in B. subtilis. 
The 22kDa protein CheC was initially identified as a possible chemotaxis protein by the 
presence of cheC gene in the B. subtilis major Che/Fla operon just like cheD [90]. The cheC 
mutant had a prestimulus rotational bias and excitation response similar to the wild-type, but 
was unable to adapt to attractant, and also the receptors in this mutant were hyper-methylated 
[90]. This indicated that CheC is important during adaptation. In addition, CheD was 
demonstrated to interact with CheC by the yeast two-hybrid experiment and the GST 
pulldown assay [91]. Interestingly, CheC regulates methylation of the chemoreceptors in B. 
subtilis by an unknown mechanism [90, 91]. Not related to this study, but interesting to note 
that CheC may have a weak interaction with CheA and McpB [52]. 
Based on above facts, I started to focus on CheC among all other chemotaxis proteins 
that could potentially regulate CheD. The focus of this chapter is on the importance of 
CheD/CheC interaction to CheD function and chemotaxis. The CheD site interacting with 
CheC was also investigated. 
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CheC Inhibits CheD Deamidase Activity 
To test the effect of CheC on CheD deamidase activity, the chemoreceptor deamidation 
assay was employed (Figure 4.1). In this experiment, receptor McpAc-term was incubated 
with CheD and with or without CheC. The same amount of reaction mixture was taken out 
and terminated by addition of 2x SDS loading buffer. As shown in Chapter 3, the wild-type 
CheD deamidates McpAc-term resulting in migrated bands on the western blot membrane. 
Another batch of CheD was pre-incubated with CheC, and then McpAc-term was added. 
CheC turned off CheD deamidase activity quickly. By 1 min, no McpAc-term deamidation 
bands were observed (Figure 4.1). This indicated that CheC can work as an inhibitor of the 
deamidase CheD.    
 
Phe102 on CheD is Required for CheC Interaction 
CheC is involved in adaptation and interacts with CheD. It seemed reasonable that the 
interaction might play a role. I wanted to investigate the site of interaction on CheD as part 
of the process of exploring for such a role.  
As shown in Figure 4.2, bacteria having CheD could be rooted into two classes based 
on CheD sequences. One class has both CheD and CheC, and the other has only CheD but 
not CheC. It is reasonable to hypothesize that CheD/CheC interaction sites are conserved in 
CheD+CheC+ strains, but not conserved in CheD+CheC- strains. Without the CheC binding 
requirement, interaction sites might have been lost during evolution. This was a clue to 
search for CheD/CheC binding sites. 
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Based on above hypothesis, the sequence of CheD in B. subtilis was aligned with CheD 
from 17 other related species (Figure 4.3). Those residues that are only conserved in 
CheD+CheC+ strains but not in CheD+CheC- strains were picked up (Figure 4.3, in black 
boxes), followed by the site-directed mutagenesis. Mutations were based on the features of 
original residues. The mutated cheD was transformed into the pGEX-6p-2 vector, 
respectively, and then proteins were purified.  
The mutated CheD proteins were used in the chemoreceptor modification assay. In this 
assay, McpAc-term was incubated with mutated CheD with or without CheC presence (all at 
2 µM) (Figure 4.4). The wild-type CheD still deamidated McpAc-term and could be 
inhibited by CheC. Without addition of CheC, both CheD(F102A) and CheD(F102E) caused 
McpAc-term deamidation. With addition of CheC to CheD(F102A), there was some receptor 
deamidation mediated by CheD, but not when CheC was added to CheD(F102E). This 
indicated that Phe102 on CheD is required for CheC interaction. 
 
The CheD/CheC Complex is Important for Chemotaxis 
To observe the CheD/CheC interaction’s effect in vivo, it was necessary to disrupt the 
interaction without affecting the individual proteins’ functions. CheD (F102E) still 
deamidated McpAc-term, indicating that mutation on Phe102 has destroyed CheD deamidase 
function. To observe its in vivo effect, the proline swarm plate assay was performed. 
Expression of the cheD(F102E) gene in the ∆cheD strain caused a swarm with a similar size 
as the ∆cheD itself, which was much smaller than the cheD complemented strain (Figure 4.5). 
This swarm plate assay showed that the association of CheD and CheC is critical for the 
normal chemotaxis in B. subtilis.  
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Discussion 
Besides its deamidase function, CheD also interacts with CheC. Impairing of 
CheD/CheC interaction showed defective chemotaxis (Figure 4.5), indicating that 
CheD/CheC interaction is critical for a robust chemotaxis. 
Initially, this study was to look for protein(s) that could bind or regulate CheD. Besides 
CheC, other proteins like CheA, CheA-P, CheY, and CheY-P were also tested for their 
potential bindings to CheD by the chemoreceptor deamidation assay (data not shown). 
Interestingly, CheC, and only CheC, showed the inhibition of CheD deamidase activity. With 
equal concentrations of CheD and CheC, CheD deamidase activity was completely inhibited 
(Figure 4.1). Phe 102 on CheD was subsequently identified as a site to interact with CheC. 
More recently, CheD has also been shown to increase the CheY-P phosphatase activity of 
CheC [111]. Asp 149 on CheC is a site to interact with CheD. Ala or Lys mutations on this 
site disrupted CheD binding, but did not influence its CheY-P phosphatase activity [24, 87].  
The CheC-CheD co-crystal structure from the Crane lab greatly improved our 
understanding of the CheD/CheC interaction [24]. Based on their structure, Phe 102 lies on 
the outside loop of CheD interacting with the α2’ helix of CheC (Figure 4.6). This is 
consistent with Phe 102 being on essential site to interact with CheC. The deamidase 
catalytic triad of CheD, C33-H50-T27, is right behind Phe 102 (Figure 4.7). Once CheC is 
recruited by Phe 102, it will block CheD active sites from chemoreceptors’ approaching so 
that no receptor deamidation can occur. By mutating the hydrophobic and bulky Phe 102 into 
a charged glutamate residue, CheD/CheC interaction was disrupted, but CheD deamidase 
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function was retained. Therefore, with or without CheC, it still deamidated receptors (as 
shown in Figure 4.4 B). In addition, since the same surface side on CheD is required for 
binding to CheC or receptor access, B. Crane also proposed that CheC mimics the receptor 
substrate in binding to CheD [24]. More details of CheD/receptor binding will be discussed 
later in Chapter 6. 
Overall, the work presented in this chapter studied the CheD/CheC interaction, and 
represents the identification of a molecular role of the protein CheC as an inhibitor of the 
deamidase CheD in the chemotaxis system. Further, the CheD/CheC interaction is necessary 
for the robust chemotaxis in vivo as demonstrated by the cheD (F102E) mutant, in which 
CheD(F102E) lacks the ability to bind CheC.  
These results are exciting. CheD can deamidate receptors and enhance CheY-P 
phosphatase activity of CheC; and CheC, on the other hand, can inhibit CheD deamidase 
activity and possesses CheY-P phosphatase activity. Putting all above into the whole B. 
subtilis chemotactic signal transduction background (Figure 1.9), there seems to be a 
feedback mechanism from CheY(p) to receptors mediated by CheD/CheC coupling proteins. 
This will be further discussed in the next chapter. 
 
 
 
 
 
 
 
 
 
63
 
 
Figures and Tables 
 
 
 
 
Figure 4.1 CheC inhibits CheD deamidase activity shown by the immunoblot of 
receptor deamidation assay. All reactions contained 1 µM of McpAc-term and equal 
concentrations of CheD or CheC. Time-course reactions were terminated by addition of 2x 
SDS loading buffer.  
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Figure 4.2 Unrooted tree of species with either CheD+CheC+ or CheD+CheC-. 
Alignment was made based on CheD sequences using ClustalW [25].  
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F102  
Figure 4.3 Sequence alignments of CheD from B. subtilis and 17 other species either 
with both CheD and CheC or with CheD alone. Species with CheD alone (CheC-) are in 
the blue box. Residues only conserved in CheD+CheC+ strains but not in CheD+CheC- 
strains are in black boxes. F102 is the site on CheD required for interaction with CheC. The 
alignment was performed with Clustal X. Species abbreviations: Aful, Archaeoglobus 
fulgidis; Atum, Agrobacterium tumefaciens; Bbur, Borrelia burgdorferi; Bhol, Bacillus 
halodurans; Bsub, Bacillus subtilis; Cace, Clostridium acetobutylicum; Ccre, Caulobacter 
crescentus; Cthe, Clostridium thermocellum; Dhaf, Desulfitobacterium hafniense; Neur, 
Nitrosomonas europaea; Oihe, Oceanobacillus iheyensis; Paer, Pseudomonas aeruginosa; 
Phor, Pyrococcus horikoshii; Rsph, Rhodobacter sphaeroides; Smel, Sinorhizobium meliloti; 
Tmar, Thermotoga maritima; Tten, Thermoanaerobacter tengcongensis; Xcam, 
Xanthomonas campestris. 
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Figure 4.4 Phe102 on CheD is required for interaction with CheC shown by the 
chemoreceptor deamidation assay. (A) Chemoreceptor deamidation assay with mutated 
CheD and with or without CheC presence. Without addition of CheC, both F102A and 
F102E showed deamidation migration. With addition of CheC, there was small increasing of 
deamidation for F102A. When mutating the hydrophobic F102 into a charged glutamate 
residue, CheC no longer inhibited CheD. (B) A separate chemoreceptor deamidation assay 
showing that F102E mutation released CheC inhibition to CheD deamidase activity.  
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Figure 4.5 The CheD-CheC interaction is critical for the robust chemotaxis in B. 
subtilis. This swarm plate assay demonstrates that the cheD(F102E) mutant gene could not 
complement a cheD-null strain. Thus, the association of CheC and CheD is necessary for the 
robust chemotaxis.   
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Figure 4.6 CheD/CheC interaction in B. subtilis. The 3-D structure was based on the 
CheC-CheD co-crystal structure from Thermotoga maritima [24]. F102 lies on the face of 
CheD that binds to the α2’ helix of CheC. 
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Figure 4.7 Coordinates of CheD active sites and CheC interacting residue Phe 102. The 
3-D structure was based on the CheC-CheD co-crystal structure from Thermotoga maritima 
[24]. Phe 102 was in red color; and CheD deamidase catalytic triad C33-H50-T27 is labeled 
in magenta.  
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Chapter 5 
The CheC-CheD-CheY-p Adaptation System 
 
Introduction 
As mentioned in previous chapters, CheC and CheD in B. subtilis are unique proteins 
that are not present in E. coli [89, 90]. CheC is a CheY-p phosphatase [110, 111], and 
inhibits CheD’s deamidase activity (Chapter 4). The cheC mutant had a prestimulus 
rotational bias and excitation response similar to the wild-type, but was unable to adapt to 
attractant, and also the receptors in this mutant were hyper-methylated [90]. This indicated 
that CheC is important during adaptation. In addition, in the cheC (N120A, N121A) mutant 
CheC could bind CheYp but without phosphatase activity, and the strain was able to perform 
chemotaxis at ~50% wild-type levels. It seems that it is more important that CheC bind to 
CheY-p or CheD than dephosphorylate CheY-p [78, 87].  
CheD, on the other hand, can enhance CheC’s phosphatase activity [111], and 
deamidate receptors by converting conserved glutamine residues to glutamates. CheD also 
interacts with receptors in the AS-1 region of receptor HAMP domains (Chapter 6), and 
makes receptors more active [56, 58]. cheD mutants have largely inactive receptors as they 
are very tumbly [52].  
Based on above results, if we put receptor, CheD, CheC, and CheY-p into one frame, it 
is reasonable to hypothesize that there may be a signal feedback mechanism from CheY-p to 
receptors through CheC-CheD coupling proteins. It could be a pathway for the cell to 
achieve adaptation. In particular, we hypothesize that once CheY is phosphorylated, the 
CheC-CheY-p complex will attract more CheD from receptors to make receptors less able to 
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activate CheA kinase [87]. Previously it has been reported that from the pulldown assay 
there was an increase of 50-70% CheC binding to CheD with CheY-p compared with CheY 
alone [78]. But this assay did not show the direct evidence of affinity change between CheC 
and CheD and was very qualitative. In order to quantitate the kinetics of affinity change 
between CheD and CheC in different environments, we chose the Surface Plasmon 
Resonance (SPR).  
Surface Plasmon Resonance is a very powerful technique to study interactions among 
different molecules, e.g. protein-protein interaction. It provides a non-invasive, label-free 
means of recording interactions between an injected analyte and an immobilized molecule in 
real time. This technique has been widely used for many different purposes, including 
affinity analysis, kinetic analysis, concentration assays, binding stoichiometry, 
thermodynamic analysis, drug screening, and more [97]. The theory of this technique is that 
if the analyte binds the ligand, the addition of mass causes a proportional increase in 
refractive index, which results into a shift in the resonance angle (Figure 5.1). The change of 
the SPR angle can be monitored in real-time by detecting changes in the intensity of the 
reflected light, producing a sensorgram (Figure 5.2). By monitoring the shift vs. time, 
molecular binding events can be monitored and kinetics of the binding events can be studied 
without labels. In particular, from the sensorgram we can calculate the association and 
dissociation constants kon and koff. Then the equilibrium dissociation constant (KD) can be 
calculated from the equation KD = koff/kon (Chapter 2).  
The sensor chip used in this study was Sensor Chip NTA (BiaCore), which is designed 
to bind histidine-tagged biomolecules for interaction analysis in BiaCore systems. The 
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surface of the chip has a carboxymethylated dextran matrix pre-immobilized with 
nitrilotriacetic acid (NTA) for capture of histidine-tagged molecules via Ni2+NTA chelation.  
The focus of this chapter is to analyze affinity changes of CheC-CheD binding under 
different situations, including CheC-CheD alone, CheC-CheD-CheY, or ChC-CheD-CheY-p. 
We want to see whether phosphorylation of CheY can affect CheC-CheD binding or not, 
which may help give credence to our previous hypothesis of the CheC-CheD-CheYp 
adaptation system. 
 
Pulldown Assay with GST-6xHis-CheD  
In order to immobilize CheD onto the surface of SPR chips, we needed to introduce a 
tag that can interact with functional groups of the surface. The sensor chip NTA was chosen 
in my SPR assays, which binds histidine-tagged biomolecules. Therefore, the 6xHis tag 
should be attached to CheD. Previous studies showed that the solubility of CheD was very 
poor with the 6xHis tag at either the N-terminal or the C-terminal end (personal 
communications with H. Szurmant and T. Muff). To increase its solubility, different versions 
of CheD with fusion tag proteins were constructed, including GST-6xHis-CheD and 
GST-CheD-6xHis in the pGEX-6p-2 vector, and 6xHis-GST-CheD in the pUSH1 vector. 
GST-6xHis-CheD (GHD) had a high yield after protein purification that is similar to that for 
GST-CheD; whereas the other two yielded little purified protein (data not shown). 
To test whether the GST-6xHis-CheD construct can actively bind CheC, a pull-down 
assay was performed (Figure 5.3). The NTA beads were used in this assay. Results have 
shown that GST-6xHis-CheD could clearly pulldown CheC, and is a good ligand protein 
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interacting with CheC in the SPR kinetic studies. In addition, when CheY-p was added, about 
1.9 fold more CheC could be pulled down compared to that with unphosphorylated CheY.  
 
SPR Analysis of CheC-CheD Interaction 
The SPR experiment was first performed to analyze CheC-CheD interaction. By this 
experiment, we could know: (1) if the SPR technique is workable for CheC-CheD kinetic 
analysis; (2) the range (KD) of CheC-CheD interaction for downstream SPR assays.  
In this SPR experiment, 500 RU of GST-6xHis-CheD was immobilized on the NTA 
chip, and different concentrations of CheC were allowed to associate to CheD with 4 min of 
association and 2 min of dissociation. Results have shown that with increasing concentration 
of CheC, the binding signal (Response Unit, RU) was also increasing proportionally. It 
indicated that SPR is a suitable technique to investigate CheC-CheD interaction, especially 
in potentially different environments, for example, with addition of CheY or CheYp. In 
addition, KD of CheC-CheD interaction was 4.1±0.3 µM calculated by the Biaevaluation 
software. These preliminary data implied a reasonable range of CheC concentration for the 
downstream CheC-CheD-CheYp experiments. 
  
SPR Analysis of CheC-CheD-CheY-p Adaptation System 
In this study, the affinity changes of CheC-CheD binding were studied with SPR under 
different circumstances, CheC-CheD alone, CheC-CheD-CheY, or CheC-CheD-CheY-p. 
Through all the experiments, 500 RU of GST-6xHis-CheD was immobilized on the NTA 
chip, and all experiments were repeated in three individual days.  
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In the study of CheD-CheC binding kinetics, 5 µM of CheC was injected (Figure 5.5).  
In the study of CheD-CheC-CheY binding kinetics, 5 µM of CheC and an excess amount of 
CheY (20 µM) were injected with the same concentration of CheY in the running buffer 
(Figure 5.6), which removed CheY background effect during buffer switching, but still let 
CheY be present to interact with CheC. The same scheme was used in the study of 
CheD-CheC-CheY-p except 5 mM of acetyl phosphate was added during injection and in the 
running buffer (Figure 5.7). Results were reasonably reproducible.  
Putting data from all three conditions together (Figure 5.8 – 5.10), we can compare the 
CheD-CheC affinity changes. The association (kon) and dissociation constants (koff), and the 
equilibrium dissociation constant (KD) were calculated according to methods in Chapter 2, 
and listed in Table 5.1. Results showed that KD of CheD-CheC binding alone was (3.95 ± 
1.06) E-06 mol/L. When unphosphorylated CheY was also added, KD for CheD-CheC was 
(7.01 ± 0.53) E-06 mol/L. And when phosphorylated CheY was added, KD was (5.46 ± 0.33) 
E-07 mol/L. We can see that after CheY was added, CheD-CheC affinity decreased by half 
compared to CheD-CheC alone. In addition, if phosphorylated CheY was present (in 
CheC-CheD-CheY-p study), CheD-CheC affinity was greatly increased by 12.8 fold 
compared to that of CheD-CheC-CheY. In addition, when CheY-p was added, kon changed 
from (1.06 ± 0.12) E+4 M-1S-1 to (1.79 ± 0.13) E+5 M-1S-1 compared to adding of 
unphosphorylated CheY, and koff changed (7.43 ± 0.79) E-2 S-1 to (9.76 ± 0.57) E-2 S-1.  
 
Discussion 
Adaptation is the ability to respond to a change in input stimulus, and return to its 
prestimulated output level. Despite its deamidase activity, we hypothesize that CheD’s main 
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role is its involvement in the CheD-CheC-CheY-p negative feedback pathway during 
adaptation. In particular, CheD is likely to help stabilize the transient kinase-activating state 
through binding to receptors. When CheY-p level is increased, CheC-CheY-p complex may 
attract CheD away from receptors. In order to understand this negative feedback pathway, in 
this study a series of SPR experiments were performed to detect CheC-CheD binding 
kinetics with CheY or CheY-p present.     
When the unphosphorylated CheY was added to CheD/CheC, the affinity of 
CheD/CheC decreased by half; and when the phosphorylated CheY was added, the affinity 
increased by 12.8 fold. If looking at the top of association curves, which is close to reaching 
the equilibrium of CheD-CheC association and dissociation, the RU change from 
CheD-CheC-CheY-p was 5.4 fold higher than that of CheD-CheC-CheY. In other words, 
when CheY is phosphorylated, 5.4 fold more CheC binds to CheD compared to when CheY 
is unphosphorylated. In addition, the half life (t1/2, equals 0.69302/ koff) of dissociation from 
above data is ranged from 7.1 S to 12.3 S, which is compatible with the observed adaptation 
rate. It showed that these data are reasonable from another point of view. 
In sum, above results show that, CheD-CheC coupling proteins work to facilitate 
adaptation in bacterial chemotaxis through a negative-feedback mechanism involving CheYp, 
a result consistent with our recent hypothesis [87]. To summarize, the scheme of adaptation 
through CheD-CheC-CheY-p: (a) The interaction between CheD and chemoreceptors makes 
the receptors more active. (b) When cells are exposed to attractant, CheAp and CheYp levels 
increase; (c) More CheY-p then binds to CheC. This complex attracts more CheD away from 
the receptors. (d) Then CheYp level is decreased, and the receptor becomes less active. (e) 
When the cell is exposed to the repellent or the attractant is removed, it goes the opposite 
 
 
76
way. In this situation, less CheAp and CheYp are produced, and less CheC-CheYp 
complexes are formed then. Therefore, more CheD binds the chemoreceptors and make 
receptors more active (Figure 5.11). 
Besides the CheC-CheD-CheYp adaptation system, the methylation system and the 
CheV system are also responsible for adaptation of B. subtilis chemotaxis, as proposed by 
Drs. C. V. Rao and G. W. Ordal [87].  
In the methylation system, methyl groups are shuttle between different sites on the 
receptor in response to the addition or removal of attractant, while the net level of 
methylation of the B. subtilis receptors appears to be fairly constant [41]. In addition, the 
receptors are rapidly demethylated (1 min) and then slowly remethylated (20 min) upon both 
addition and removal of attractant [42, 43]. Another unique feature of the B. subtilis 
methylation system is that the glutamate residues get selectively methylated, which can 
either stimulate or inhibit the CheA kinase [96]. For example, McpB has three methylation 
sites located at Glu371, Glu630 and Glu637. Upon addition of attractant, the cell adapts by 
the demethylation of residues 371 and 630. Upon removal of attractant, sites 630 and 637 get 
demethylated, so that the cell adapts and the receptors to return to pre-stimulus levels [96]. 
Homology modeling shows that these three methylation sites on McpB form a tight cluster 
on the outward face of McpB. Charge-charge repulsion between them likely to affect 
receptor stability and associated kinase activity [87].  
Similar to CheC-CheD-CheYp system, the CheV system is also through a negative 
feedback loop. CheV has two domains, an N-terminal CheW-like coupling domain and a 
C-terminal response-regulator domain that can be phosphorylated by CheA. Upon 
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phosphorylation, it could yield a conformational change that inhibits CheA kinase activity, 
likely by disrupting the receptor complex [46, 87].  
It is still unclear yet how these three adaptation systems are coordinated. Further studies 
are required in each adaptation system before we can integrate all three systems.  
It has been reported that despite the diverse adaptation pathways in biological systems, 
there are only a finite set of solutions for robustly achieving adaptation [63]. In their study, 
all possible three-node enzyme network topologies were computationally searched to 
identify those that could perform adaptation. Only two major core topologies have emerged 
as robust solution: a negative feedback loop with a buffering node and an incoherent 
feedforward loop with a proportioner node [63]. In our case, the CheC-CheD-CheYp system 
and the CheV system belong to the classic negative feedback loop pathway. The CheC-CheD 
coupling proteins and CheV serve as a buffering node that can potentially fine tune the 
output. The methylation system in E. coli also belongs to the classic negative feedback 
pathway with CheR and CheB affected methylation level serving as buffering nodes. The 
methylation system in B. subtilis is more complicated, since the net methylation level during 
adaptation is almost constantly same and the (de)methylation is selective. We may treat it as 
a modified negative feedback system with the special pattern of combinations of 
methylation/demethylation as the buffering node, which can be affected by CheR/CheB as in 
E. coli.  
Overall, in the study I successfully obtained CheC-CheD binding kinetics with CheY or 
CheYp presence by a series of SPR experiments.  The increased affinity of CheD for CheC 
in presence of CheYp but not CheY makes likely the hypothesis that CheC-CheD-CheY 
interact as part of a negative feedback pathway during adaptation. 
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Figures and Tables 
 
Table 5.1 Kinetic parameters of CheC-CheD binding from SPR experiments.  
 
K s k off k on K D
Unit (S-1) (S-1) (M-1S-1) (M)
CheC-CheD1 0.1468 0.0613 17100 3.58E-06
CheC-CheD2 0.1213 0.0466 14940 3.11E-06
CheC-CheD3 0.1234 0.0626 12160 5.15E-06
Average 0.1305 0.0568 14733 3.95E-06
SD 0.0141 0.0089 2476 1.06E-06
CheC-CheD-CheY1 0.1394 0.0829 11300 7.34E-06
CheC-CheD-CheY2 0.129 0.0724 11320 6.40E-06
CheC-CheD-CheY3 0.1138 0.0675 9260 7.29E-06
Average 0.1274 0.0743 10627 7.01E-06
SD 0.0129 0.0079 1184 5.30E-07
CheC-CheD-CheY-p1 1.0718 0.103 193760 5.32E-07
CheC-CheD-CheY-p2 0.967 0.0916 175080 5.23E-07
CheC-CheD-CheY-p3 0.9385 0.0982 168060 5.84E-07
Average 0.9924 0.0976 178967 5.46E-07
SD 0.0702 0.0057 13284 3.31E-08  
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Figure 5.1 Surface plasmon resonance detection unit. L: light source, D: photodiode array, 
P: prism, S: sensor surface, F: flow cell. The two dark lines in the reflected beam projected 
on to the detector symbolise the light intensity drop following the resonance phenomenon at 
time = t1 and t2. Adapted from http://www.astbury.leeds.ac.uk.  
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Figure 5.2 Schematic of SPR kinetic analyses. Adapted from Biacore web site 
(www.biacore.com).  
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Figure 5.3 GST-6xHis-CheD pull-down assay. The Coomassie stained SDS-PAGE shows 
a pull-down experiment demonstrating the interaction of GST-6xHis-CheD with CheC (lane 
2), with CheC and CheY (lane 3), and with CheC and CheY-p (lane 4). Lane 1 is a control, 
which had GST-6xHis-CheD alone. The NTA beads were used in this assay. Results have 
shown that GST-6xHis-CheD could pulldown CheC, and is a good ligand protein that can be 
potentially used in the SPR experiments. In addition, when CheY-p was added, about 1.9 
fold more of CheC could be pulled down compared to that with unphosphorylated CheY. 
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Figure 5.4 SPR analysis of the interaction between CheD and CheC. Different 
concentrations of CheC were allowed to associate to GST-6xHis-CheD on the NTA chip 
with 4 min of association and 2 min of dissociation.  
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Figure 5.5 SPR analysis of the interaction between CheD and CheC. 5 µM of CheC was 
allowed to associate to GST-6xHis-CheD on the NTA chip with 4 min of association and 2 
min of dissociation. Data were from three independent dates. 
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Figure 5.6 SPR analysis of CheC-CheD interaction with CheY presence. 5 µM of CheC 
and an excess amount of CheY (20 µM) were injected and allowed to associate to 
GST-6xHis-CheD on the NTA chip with 4 min of association and 2 min of dissociation. The 
same concentration of CheY was added in the running buffer. Data were from three 
independent dates. 
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Figure 5.7 SPR analysis of CheC-CheD interaction with CheYp presence. 5 µM of CheC, 
an excess amount of CheY (20 µM), and 5 mM of acetyl phosphate were injected and 
allowed to associate to GST-6xHis-CheD on the NTA chip with 4 min of association and 2 
min of dissociation. The same concentrations of CheY and acetyl phosphate were added in 
the running buffer. Data were from three independent dates. 
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Figure 5.8 CheY-p increased CheD-CheC affinity shown by SPR (day 1). Blue color: 
CheD-CheC; green color: CheD-CheC-CheY (unphosphorylated); and red color: 
CheD-CheC-CheY-p (phosphorylated).    
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Figure 5.9 CheY-p increased CheD-CheC affinity shown by SPR (day 2). Blue color: 
CheD-CheC; green color: CheD-CheC-CheY (unphosphorylated); and red color: 
CheD-CheC-CheY-p (phosphorylated).  
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Figure 5.10 CheY-p increased CheD-CheC affinity shown by SPR (day 3). Blue color: 
CheD-CheC; green color: CheD-CheC-CheY (unphosphorylated); and red color: 
CheD-CheC-CheY-p (phosphorylated). 
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Figure 5.11 Model for the CheC-CheD-CheY-p adaptation system in B. subtilis. (a) The 
interaction between CheD and chemoreceptors makes the receptors more active; (b) When 
cells are exposed to attractant, CheAp and CheYp levels are increased sequentially; (c) More 
CheY-p then binds to CheC. This complex attracts more CheD away from the receptors. (d) 
Then CheYp level is decreased, and the receptor is less active. (e) When the cell is exposed 
to the repellent or the attractant is removed, it goes to the opposite way. In this situation, less 
CheAp and CheYp are produced, and less CheC-CheYp complexes are formed then. 
Therefore, more CheD binds the chemoreceptors and make receptors more active. This 
figure was adapted from reference [87]. 
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Chapter 6 
Interaction between CheD and McpC 
 
Introduction 
The cheD knockout mutant shows a chemotactic defect, is less sensitive to attractants, 
more tumbly, and has poorly methylated chemoreceptors [52, 56, 90]. Through an unknown 
mechanism, CheD was reported to interact with receptors [32, 90, 91]. Therefore, we assume 
that CheD can make receptors more active either directly or indirectly.   
McpC, the sole proline receptor, responds to a variety of attractants, and is probably the 
most important receptor among the MCP chemoreceptor family. It responds to all amino 
acids except asparagine, and many PTS sugars [57, 79, 81]. Interestingly, McpC is the only 
chemoreceptor that absolutely requires CheD for the normal chemotaxis. Other receptors like 
McpB can still have appreciable but subnormal taxis without CheD [52, 58]. Addressing how 
McpC and CheD interact with each other can help us understand this special CheD 
requirement and how CheD makes receptors more active. 
Particularly, we recently thought that there are three adaptation systems in B. subtilis, 
and CheD is involved in the CheD-CheC-CheYp negative feedback pathway [87]. Once 
CheY is phosphorylated, the CheC-CheYp complex can attract more CheD from receptors, 
which will make receptors and thus CheA less active. Elucidating the interaction between 
McpC and CheD can help us better understand the role of CheD in adaptation. 
Previously C. Kristich in our lab made several McpB-McpC receptor chimeras 
including the one swapping the AS-1 region of McpC HAMP domain by that of McpB 
(Figure 6.1). The new McpCBC, interestingly, became CheD-independent, whereas on 
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swarm plates McpB324C and McpC317B had phenotypes similar to McpB and McpC, 
respectively. By his work, he narrowed down that AS-1 region could contain the information 
that McpC requires CheD [58].  
The focus of this chapter is on identification of the sites on McpC that are required to 
recruit CheD. Some additional protein expression and protein modeling work have also been 
done to validate those sites that were discovered. 
 
Strategy of Identification of Putative McpC Sites that Recruit CheD 
Based on C Kristich’s work the HAMP domain of McpC, especially the AS-1 region, 
most likely contains the information that recruits CheD. AS-1 region is a small 12-residue 
region. Like most other protein-protein interactions, CheD-McpC interaction may occur 
through hydrophobic, polar or charged residues. Therefore, six sites on McpC AS1 region 
were selected including P302, Q304, Q305, K309, T310, and K311 (Figure 6.1), and then 
were mutated into alanine on the full-length McpC in pAIN750 vector. After transformation 
into B. subtilis, the mutant phenotypes were screened on the swarm plates. Those that were 
defective in taxis were identified. 
 
Q304 and Q305 on McpC AS-1 Region are Required to Recruit CheD 
After site-directed mutagenesis, the plasmids were then transformed into the amyE 
locus of ∆10 strain, which lacks all 10 chemoreceptors, and then selected for spectinomycin 
resistance. The selected mutants were then analyzed on swarm plates, and examined whether 
these mutants could form a chemotactic ring towards proline in the presence of CheD 
activity. 
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The mcpC complemented strain in ∆10 background was capable of supporting 
chemotactic ring formation in the presence of CheD, whereas ∆10 could not. Surprising to us, 
in the presence of CheD, the Q304A and Q305A mutants in the AS-1 region did not form a 
clear chemotactic ring, and only diffused within a small region as ∆10 did (Figure 6.2). Thus, 
in either of these mutants, CheD could no longer activate McpC. Therefore, Q304 and Q305 
on McpC are most likely the sites required to bind CheD. More supporting evidence will be 
discussed at follows. 
 
Expression of CheD in McpC Q304 and Q305 Mutants 
Recently V. Cannistraro in the lab found that the expression level of CheD seems to be 
tuned to give the functional ratio of protein need to participate in adaptation. When the 
binding counterparts of CheD are deleted (cheC and all 10 receptors), the CheD level drops 
significantly. In detail, CheD protein levels in the ∆10 background are about 19% of 
wild-type, and 32% of wild-type in the cheC null (V. Cannistraro Ph.D. thesis). Therefore, 
we would like to see if CheD levels have any change when it is no longer recruited by McpC 
in Q304A and Q305A mutants as evidenced by reduced total levels of CheD. 
For this purpose, 8 different strains with ∆10 background were grown in the minimum 
medium, and western blots were then performed with anti-CheD antibody to the cell lysates. 
These strains included ∆10, ∆10∆cheD, ∆10mcpB, ∆10mcpC, ∆10mcpCBC, 
∆10mcpC(Q304A), and two isolates of ∆10mcpC(Q305A). The ∆10 receptor background can 
remove all potential background of CheD-receptor interactions. Only those complemented or 
mutated receptors could possibly interact with CheD.  
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The bands corresponding to CheD were later quantified using LabWork software 
(Figure 6.3). The CheD levels in ∆10mcpC(Q304A) and ∆10mcpC(Q305A) are 
approximately 52.8% and 69.8% as in ∆10mcpC, respectively (Figure 6.3). The reduced 
CheD level may suggest that CheD is more exposed to proteolysis when unbound or 
protected from receptors. In addition, the CheD levels in ∆10mcpB and ∆10mcpCBC are 
similar to ∆10mcpC.  
 
CheD May Need the Receptor Homodimer Structure to be Recruited 
To investigate CheD/McpC interaction, I firstly used McpC C-terminal part as the 
mutation target. After mutating different sites mentioned before, each mutated protein was 
purified. Then NTA beads pulldown assay and SPR were used for screening purpose. But 
surprisingly, no obvious binding was observed on CheD with even McpCc-term (although G. 
Glekas in the lab could see the binding by the GST pull-down assay). In pulldown assays, 
McpCc-term with CheD had a similar level of “binding” as without CheD. Especially, SPR 
is a very sensitive tool to study protein-protein interaction. But even at the high 
concentration of McpCc-term (20µM), no obvious binding was found with CheD.  
Another source of evidence could be from using of ProFound protein interaction 
mapping kit (PIERCE) to search for McpCc-term and CheD interaction. The theory is that 
when one protein is bound by another, the interaction area will be protected from cleavage 
reagents, which can be revealed by western blots. With this kit I used McpCc-term and CheD, 
but no protection areas were found, and the McpCc-term was completely digested (data not 
shown). This suggested that there is no obvious binding between CheD and McpCc-term.  
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Based on above evidence, the c-terminal part of receptor monomer may not be enough 
to recruit CheD. Remember that in B. subtilis chemoreceptors are long α-helical homodimers 
[83], I assume that the quaternary homodimer structure of receptors is needed to recruit 
CheD, and the packed four helices in HAMP domain together may be required for CheD 
recognition. Alternatively, the structure of the HAMP domain is different in the full-length 
receptor than in the C-terminal receptor. 
 
Structure Homology Modeling of QQ sites in McpC AS-1 Region 
The four-helix arrangement of receptor HAMP domain is a parallel coiled coil that can 
have two alternative conformations influenced by binding of attractant in the region outside 
the membrane [7]. By this way the upstream extra-cellular signal information can be 
transferred to the downstream highly conserved domain (HCD), which interacts with the 
CheA kinase. It is possible that alanine substitutions of Q304 and Q305 could alter the 
internal structure of McpC and let it mis-folded after expression. To remove this possibility, 
protein structure homology modeling of McpC HAMP domain was performed in 
SWISS-MODEL database (Figure 6.4)[12].  
The modeling was based on the matching template 2asxB, the HAMP domain of the 
receptor AF1503 from Archaeoglobus fulgidus [43], error rate 3.20E-11, 28.302% sequence 
identity. This is a very good matching.  
From the model picture, we can clearly see that Q304 and Q305 are facing towards 
outside of the HAMP domain. It is very unlikely that substitutions of these two residues into 
alanine will alter its four helices homodimer structure. The signal flux through helix rotating 
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should not be influenced significantly. Therefore, these two mutated McpC should still be 
able to fold properly.  
On the other hand, the polar groups of Q304 and Q395 put McpC into a good position 
to interact with CheD. These glutamine polar groups are facing extruded of the helices 
homodimer, and are more convenient to connect with CheD, presumably at S32 site on CheD 
according to Crane’s model [24].  
 
Discussion 
Despite its deamidase activity, we hypothesize that CheD’s main role is its involvement 
in the CheD-CheC-CheYp negative feedback pathway. In particular, CheD is likely to help 
stabilize the transient kinase-activating state through binding to receptors. When CheYp 
level is increased, CheC-CheYp complex may attract CheD away from receptors [87]. In 
order to understand this negative feedback pathway, it is critical to address how CheD 
interacts with receptors and how this interaction tunes the downstream CheA kinase 
activation. Since we knew that McpC absolutely requires CheD for its normal taxis, it is 
reasonable to start from the CheD/McpC interaction. 
Previous studies from McpB/McpC receptor chimeras showed that the AS-1 region of 
McpC HAMP domain most likely has the determinant sequence recruiting CheD. In this 
study, two point mutations have been made in the AS-1 region of McpC HAMP domain to 
study this interaction. 
HAMP domains are a relatively conserved domain, widely existing in many signaling 
proteins in bacteria and archaea, which converts the signal from sensory input modules to 
output modules. It is usually a 50-residue motif located right after the transmembrane 
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domain (TM) and immediately inside the cytoplasmic membrane. It is named for its presence 
in histidine kinases, adenylyl cyclases, chemoreceptors (methyl-accepting chemotaxis 
proteins, MCPs), and some phosphatases. HAMP domains consist of 4 α-helices 
homodimers. In each monomer, there are two short amphipathic α-helices (12 –residue of 
AS-1 and 15-residue of AS-2) joined by a flexible connector [7-9, 43]. Although the 
structure of HAMP domain has been resolved by NMR [43], the detail mechanism how 
HAMP transfers signal from the upstream sensing module to the downstream output module 
is yet to be explained.       
In this study, I found that Q304 and Q305 in the AS-1 region of McpC HAMP domain 
are likely part of the determinant sequences that recruit CheD. When viewing them in the 
3-D structure, these two residues are clearly facing towards outside of helix rotating axis. 
This is important, because the polar side group of glutamine extruded from the helix axis can 
potentially interact with other proteins, like CheD. 
It is noteworthy to notice that CheD deamidase activity is not required for McpC 
mediated intramolecular signal transduction. K. Kristich mutated Q304 and Q305 into 
glutamate (in fact, CheD may not deamidate these two glutamine at all), and found that the 
mutants still need CheD for normal taxis on swarm plates [58]. Therefore, CheD’s main role 
in regard to the receptor HAMP domain is not deamidation, but is probably to facilitate 
CheA activation.   
We were also interested to see if CheD levels have any change when it is no longer 
recruited by McpC in Q304A and Q305A mutants. For this purpose, CheD levels were tested 
from 8 different strains with ∆10 background. The CheD levels in ∆10mcpC(Q304A) and 
∆10mcpC(Q305A) are approximately 52.8% and 69.8% as in ∆10mcpC, respectively (Figure 
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6.3). The reduced CheD level may suggest that CheD is more exposed to proteolysis when 
unbound or protected from receptors (or CheC as in V. Cannistraro thesis). Therefore, the 
dynamic interaction among CheD, receptors and CheC are vital to maintain the normal CheD 
level. It has been reported that CheW is subject to Clp and ClpX-mediated proteolysis during 
glucose starvation in B. subtilis [33]. This may be the similar situation. It will be interesting 
to see if CheC levels vary in a similar way. Potentially in vitro enzyme protection 
time-course experiments can be done to verify this hypothesis with incubating of purified 
CheD, receptor, or CheC under a general digestion enzyme background. 
Surprisingly, the CheD levels in ∆10mcpB and ∆10mcpCBC are similar to ∆10mcpC. 
We originally thought that without McpC AS-1 region, the CheD levels would be lower in 
∆10mcpB and ∆10mcpCBC, since CheD is not necessary to couple with receptor in these 
cases. These results may suggest that besides being recruited by McpC, CheD may have 
general roles on all chemoreceptors through protein association. It is not necessary to be 
deamidation because most likely deamidation is only a small part of CheD functions. The 
deamidation of receptors occurs only once, and it is very costly to synthesize receptors again. 
McpC absolutely requires CheD in order to carry out taxis, but somehow CheD may work on 
all receptors to make them more active, as evidenced by that ∆10 cheD mcpB has less 
efficient taxis than ∆10mcpB (G. Glekas Ph.D. thesis).  
Overall, Q304 and Q305 are essential for CheD recruitment to McpC. CheD’s structure 
association, instead of deamidation function, is important to McpC mediated signal 
transduction. With McpC Q304A, Q305A, and CheD S32A, C33A mutants, we may further 
study how exactly CheD helps activate receptors, and how CheD helps tune the downstream 
kinase activation. 
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Figures and Tables 
 
 
 
 
 
 
Figure 6.1 Schematic of the HAMP regions of wild-type and chimeric receptors. 
Sequences derived from McpB are in plain type, whereas sequences derived from McpC are 
presented on a gray background [58]. This figure is a reproduction from the reference. 
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Figure 6.2 Swarm plate screening of McpC AS-1 mutants. Swarm plates were composed 
of minimal medium supplemented with proline as the attractant. All strains were assayed a 
minimum of six independent times. Results from a representative experiment are shown. The 
image was processed using LabWork to maximize contrast. 
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Figure 6.3 Expression of CheD in McpC Q304 and Q305 mutants. In both figure A and B, 
1: ∆10mcpB; 2: ∆10mcpC; 3: ∆10mcpCBC; 4: ∆10; 5: ∆10 cheD; 6: ∆10mcpC(Q304A); 7: 
∆10mcpC(Q305A), strain 1; 8: ∆10mcpC(Q305A), strain 2; 9: 10 pmol of purified CheD 
loaded as the molecular weight marker. (A) Anti-CheD Western blot picture in ∆10 
background strains. The whole cell lysate from 5.2E+07 cells were loaded per lane, and 
1:400 anti-CheD antibody was added for each blot. (B) Quantified band density on above 
western blot picture.  
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Figure 6.4 Structure modeling of McpC HAMP Domain. The 3-D structure was obtained 
from SWISS-MODEL database. Two Q304 and Q305 residues facing towards outside 
α-helical homodimers are in purple color.  
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